本文由 ATOS阿托斯液壓上海銷售處 整理匯編

2018-09-29 10:01 850閱讀次數(shù)

收藏 評(píng)價(jià) 舉報(bào)

• 分享

立即下載

參與評(píng)論

評(píng)論

登錄后參與評(píng)論

登錄或新用戶注冊(cè)

• 微信登錄
• 密碼登錄
• 短信登錄

請(qǐng)用手機(jī)微信掃描下方二維碼
快速登錄或注冊(cè)新賬號(hào)

微信掃碼，手機(jī)電腦聯(lián)動(dòng)

注冊(cè)登錄即表示同意《儀器網(wǎng)服務(wù)條款》和《隱私協(xié)議》

賬  號(hào)：

密  碼：

圖片碼： 看不清？
換一張？

手機(jī)和郵箱號(hào)注冊(cè)新賬號(hào)>> 忘記密碼？

手機(jī)號(hào)：

圖片碼： 看不清？
換一張？

短信碼： 獲取短信碼

手機(jī)和郵箱號(hào)注冊(cè)新賬號(hào)>> 忘記密碼？

更多資料

• 派克比例閥價(jià)格表

  派克比例閥價(jià)格表派克PARKER電磁閥、派克PARKER止回閥、派克PARKER比例閥、派克PARKER單向閥、派克PARKER伺服閥、D41FHB31C1NE00D41FHB31E1NE00D41FHE01C1NB00D41FHB31C1NE0048D41FHB31E1NB0048D41FHE01C1NB00D41FHE01C1NE00D41FHE01E1NB00D41FHE01E1NE00D41FHE01F1NE00D41FHE01F4NB00D31FBE01CC4NF00D31FHE01A4NB00D3FXE01HCNBJ00D91FBE01HC1NF00D41FHB31C1NB00D41FHB31E1NE00D41FHB31F1NB00D41FHB31F1NE00D91FBE01HC1NG00D91FHB31F1NE00D31FBE01CC1NF00D31FBE01CC1NG00D41FBE01FC1NF00D41FBE01FC1NG00D41FBE01FC4NF00D41FBE02FC1NF00D91FBB32HC4NG00D91FBE01HC4NF00D111FBB32LC1NG00D111FHE01L4NB00BD1AABN10D1FVE02BCVFOA37PGP517A0330CD1H3NL3L2B1B1PV016R1K1T1NMMCPV028R1K1JHNMMCPV028R1L1T1NMMCPV032R1K1T1NMMCPV046R1K1T1NMMCPV046R1L1T1NMMCPV080R1K1T1NMMCPV092R1K1T1NMMCPV140R1K1T1NMR1PV180R1K1T1NMMCSSRB080E065004072TE0330CW260AAABBD1AANB10PV046R1K1T1NMRDD41FTE01FC2NF0038TE0330CW260AAABPCD00A-400PV140R1K1T1NFR1RE10R25W4SN1XWMPVS2Z140C1E015N3571A1E010N35870D1400520171D0059422PWD00A-400VRD350-010-006D31FTE02CC4NG00D31FTE01CC4NG00RE32E17T1SNG0D91FTE02HC4NG00D91FTE01HC4NF0040SD500A06V+H06SDVD3W004CNJWRDM2PT35KVG15D1VW011CNJWPRDM2PP16SVGCVH161PSVH101S20FV102SCV102PD31FHE02C1NB0040TE0330CW260AAABSD500A06V+H06SDVPVS08AZ140C2R4R03-535-11B1D3W1CNJP30D31FHE02C1NB00404D01-3208-0302-B1-GOQBD1AABN10PV016R9K1T1NMMCK0188R4V03-533-10-P2GOPA1DWEE527P20ELAFPV023R1K1T1NMM1EPP34CC1I60010PV140R1K1TINFR1BD1AABN10派克PARKERHerlT5F-CO2DN50PV140R1K1TINFR1PV023R1K1T1NMR1D3W1CNJP30PS100-POHODBD1VW20DVJW75D41VW004C1NJWDDSVZDV-ABS-02-5-S0-D1V-C1DB101E320S9900D91FWB32HC4NLW028D1VW020DNJWD41VW020D1NJWR4V1053511A1D1FVE02BCF0A37CPOM6AAVDK-D1VW75-10D3W4CNJWD41FTE01FC1NF0040D3W004CVJWCPOM4AAHTVC032BN12VPRDM2PP16SVGD3W20BNJWD1VW020HVJWD81VW020D1VJWCPOM6DDVC063AA20VSVLB1086E32SD3W4CNJWPVCRER1N1PVACPPCMN35R4V03-533-10-P2GOPA1PRDM2PP06SVGPRDM2PP16KVG15D1VW034CNJWD3W001CNTWPRDM2PT35KVGD31FHE02C1NBOOD1VW020BNJW91FM3DDSV51PD140PS02SRSC00S100D3W004CNJWD3W020BNJW42PD100PS02SRSC10S300公司主要做歐美品牌，我們?cè)诘聡?guó)、美國(guó)有公司，可以采購(gòu)歐洲任何國(guó)家的品牌，比如德國(guó)的優(yōu)勢(shì)品牌有：德國(guó)寶德BURKERT，德國(guó)DEMAG德馬格、德國(guó)HAWE哈威，德國(guó)REXROTH力士樂，德國(guó)HYDAC賀德克，德國(guó)PILZ皮爾茲繼電器，德國(guó)FESTO費(fèi)斯托,德國(guó)IFM易福門傳感器，德國(guó)E+H恩德斯豪斯，德國(guó)海德漢HEIDENHAIN,德國(guó)P+F倍加福傳感器，德國(guó)施克SICK,德國(guó)TURCK圖爾克，德國(guó)HIRSCHMANN赫斯曼工業(yè)交換機(jī)。德國(guó)亨士樂，德國(guó)MURR穆爾，德國(guó)施邁賽SCHMERSAL，德國(guó)SAMSON薩姆森，德國(guó)EPRO艾默生旗下美國(guó)MOOG穆格，美國(guó)ASCO電磁閥，美國(guó)MAC電磁閥，美國(guó)NUMATICS紐曼蒂克，美國(guó)PARKER派克氣動(dòng)液壓，美國(guó)VICKERS威格士，美國(guó)ROSS英國(guó)海隆諾冠NORGREN意大利OMAL歐瑪爾,意大利ATOS阿托斯，意大利CAMOZZI,意大利UNIVER,意大利康茂盛派克PARKER過濾器、派克PARKER液壓缸、派克PARKER柱塞泵、派克PARKER液位控制器、派克PARKER進(jìn)料泵派克比例閥價(jià)格表[詳細(xì)]

  2018-09-29 10:01

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• 派克比例閥D41FHB31E1NE0048下載

  派克比例閥D41FHB31E1NE0048下載PARKER派克比例閥被用于控制流量，具有集成的電子元件，主級(jí)的閥芯位置可調(diào)。典型的應(yīng)用是：流量控制極ng確和可實(shí)現(xiàn)流量調(diào)節(jié)，在快速/低速特性下的工作運(yùn)行帶有閥芯位置監(jiān)控用于：壓力機(jī)控制，動(dòng)態(tài)位置調(diào)節(jié)和壓力/流量閉環(huán)系統(tǒng)。技術(shù)特性：泄漏量小，高頻響，通油能力大，準(zhǔn)確的故障狀態(tài)診斷，零遮蓋閥的機(jī)械式零點(diǎn)調(diào)節(jié)，高強(qiáng)度，閥芯位置的位移反饋，可選擇閥芯位置行程監(jiān)控。派克比例閥現(xiàn)貨供應(yīng)型號(hào)如下：D41FHE01F1NE00現(xiàn)貨1臺(tái)D41FHE01E1NB00現(xiàn)貨1臺(tái)D41FHB31C1NB0048D41FHB31E1NE0048D41FHB31F1NE0048D41FHE01E1NE0048D41FHE01F1NE0048D41FHE01F1NB0048D41FHE02E1NB0048D41FHE02F4NE0048D41FHB31E1NB0048D41FHB31F1NB0048D41FHB32C4NS0048D41FHE01F4NB0048D41FHB32C1NB0048D41FHE02C2VS0048D46FHE01F4NB0048D46FHE52B5NB0048D41FHB31F2NB0048D41FHE01B4NB0048D41FHE01E1NB0048D41FHE52B1NB0048D41FHB63E2NB0048D41FHB32E2NB0048D41FHB31C1NE0048D41FHB31E4NE0048D41FHB32C2VS0048D41FHE01C1NB0048D41FHE01C1NE0048D41FHE01C4NB0048D41FHE01E4NB0048D41FHE01F4NE0048D41FHE02F2NB0048D41FHE01F5NB0048D41FHE52F2NE0048D41FHA31C1NB0048D41FHA31F1NB0048D41FHA32F2NB0048D41FHA61B4NB0048D41FHA61F1NB0048D41FHA61F4VB0048D41FHB31C2NB0048D41FHB31F2NE0048D41FHB31F4NB0048D41FHB32F1NB0048D41FHB32F2NB0048D41FHB32F4NB0048D41FHB34F1NB0048D41FHB34F4NB0048D41FHB61B4NB0048D41FHB61B4VB0048D41FHB61C2NE0048D41FHB61C4NB0048D41FHB61F2NB0048D41FHB61F2NE0048D41FHB61F4NB0048D41FHB63C4NB0048D41FHB63C4NB20D41FHB63E4NB20D41FHB83F2NB0048D41FHB83F4NB0048D41FHB83F5NB0048D41FHE01C2NB0048D41FHE01C4VB0048D41FHE01C5NB0048D41FHE01E2NB0048D41FHE01F1NB08D41FHE01F1VB0048D41FHE01F2NB0048D41FHE02C4NB0048D41FHE02F1NB0048D41FHE02F4NB0048D41FHE52B1VB0048D41FHE52B4NB0048D41FHE52C2NB0048D41FHE52C4NB0048D41FHE52C4VB0048D41FHE52C5NB0048D41FHE52F1NB0048D41FHE52F2NB0048D41FHE52F2VB0048D41FHE52F4NB0048D41FHE52F4VB0048D41FHE52E5NB0048D41FHE01B1NB0048D41FHB61B1NB0048D41FHA32C1NB0048D41FHE52E4NB0048D41FHB32C2NB0048D41FHB61F5NB0048D41FHB61E2NB0048D41FHE02B4NB0048D41FHB32B1NB0048D41FHE52C1NB0048D41FHB61C1NB0048D41FHE52F5VB0048派克比例閥D41FHB31E1NE0048下載[詳細(xì)]

  2018-10-06 10:02

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• PARKER派克葉片泵、PARKER派克柱塞泵現(xiàn)貨價(jià)格表

  PARKER派克葉片泵、PARKER派克柱塞泵現(xiàn)貨價(jià)格表PARKER派克公司是世界yi流的企業(yè)，制造各種元件和系統(tǒng)，用于控制各種機(jī)械和其他設(shè)備的運(yùn)動(dòng)、流量和壓力。派克提供1400多條生產(chǎn)線，用于1000多個(gè)工程機(jī)械、工業(yè)和航空航天領(lǐng)域內(nèi)的項(xiàng)目。PARKER派克是**一家能夠給她的客戶提供液壓、氣動(dòng)、機(jī)電一體化和計(jì)算機(jī)運(yùn)動(dòng)控制解決方法選擇的制造商。此外，在我們的領(lǐng)域內(nèi)我們有Zda的銷售網(wǎng)絡(luò)，遍布的7500多個(gè)銷售商為400000多個(gè)用戶提供服務(wù)。PARKER派克葉片泵、PARKER派克柱塞泵現(xiàn)貨價(jià)格表PV270R1K1T1NMMCPARKERPV270R1K1T1WMMCPARKERPV180R1K1T1NMMCPARKERPV140R1K1T1NMMCPARKERPV040R1K1T1NMMCPARKERPV046R1K1T1NMMCPARKERPV032R1K1T1NMMCPARKERPAVC10038R4222PARKERPAVC100R4222PARKERBD1AANB10PARKER701-00600-8PARKERD1FVE02BCVF0APARKERD1VW001CNJW91PARKERD1VW004CNJW91PARKER1860410-30-24(S1-024000)6通徑閥24V線圈PARKER1860152-J(1860152-J-1)10通徑閥24V線圈PARKERPAVC65R4213PARKERPV016R1K1T1NMMCPARKERD1FVE50BCVLB35PARKERPV032R1K1T1NMMCPARKERPWD00A-400PARKERPCD00A-400PARKERPV040R1K1T1NMMCPARKERD41FBE01FC1NF0010PARKERD41FBE01FC4NF0010PARKERD41FBE02FC1NF0010PARKERD91FBE01HC1NF0010PARKERD31FBE01CC1NF00PARKERD31FHE02C1NB00PARKERD3W004CNJW42PARKERD3W001CNJW42PARKERDG34PARKERDG35PARKERDG365PARKERD41FHE01C2NB00D41FHE02C1NE00D41FHB32C2NB00D41FHE01E1NE00D41FHB31F2NB00D41FHE01F4NB00D41FHE01F1NE00D41FHB31E1NE00D41FHB31F1NE00PARKERDDSVPARKERFM3DDDSVPARKERFM3DDSVPARKERCPOM3DDVPARKERCPOM2DDVPARKERDDKVPARKERFM3DDKV"PARKER公司主要做歐美品牌，我們?cè)诘聡?guó)有公司，可以采購(gòu)歐洲任何國(guó)家的品牌，比如德國(guó)的優(yōu)勢(shì)品牌有：德國(guó)寶德BURKERT，德國(guó)DEMAG德馬格、德國(guó)HAWE哈威，德國(guó)REXROTH力士樂，德國(guó)HYDAC賀德克，德國(guó)PILZ皮爾茲繼電器，德國(guó)FESTO費(fèi)斯托,德國(guó)IFM易福門傳感器，德國(guó)E+H恩德斯豪斯，德國(guó)海德漢HEIDENHAIN,德國(guó)P+F倍加福傳感器，德國(guó)施克SICK,德國(guó)TURCK圖爾克，德國(guó)HIRSCHMANN赫斯曼工業(yè)交換機(jī)。德國(guó)亨士樂，德國(guó)MURR穆爾，德國(guó)施邁賽SCHMERSAL，德國(guó)SAMSON薩姆森，德國(guó)EPRO艾默生旗下美國(guó)MOOG穆格，美國(guó)ASCO電磁閥，美國(guó)MAC電磁閥，美國(guó)NUMATICS紐曼蒂克，美國(guó)PARKER派克氣動(dòng)液壓，美國(guó)VICKERS威格士，美國(guó)ROSS英國(guó)海隆諾冠NORGREN意大利OMAL歐瑪爾,意大利ATOS阿托斯，意大利CAMOZZI,意大利UNIVER,意大利康茂盛PARKER派克葉片泵、PARKER派克柱塞泵現(xiàn)貨價(jià)格表[詳細(xì)]

  2018-09-29 10:01

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• PARKER派克比例閥D41FHE01C1型號(hào)下載

  PARKER派克比例閥D41FHE01C1型號(hào)下載Parker派克比例閥Parker派克D41FH系列先導(dǎo)式比例換向閥此系列先導(dǎo)式比例換向閥被用于控制流量。該閥具有集成的電子元件，主級(jí)的閥芯位置可調(diào)。典型的應(yīng)用是：流量控制極ng確和可實(shí)現(xiàn)流量調(diào)節(jié)，在快速/低速特性下的工作運(yùn)行帶有閥芯位置監(jiān)控用于：壓力機(jī)控制，動(dòng)態(tài)位置調(diào)節(jié)和壓力/流量閉環(huán)系統(tǒng)。技術(shù)特性：泄漏量小，高頻響，通油能力大，準(zhǔn)確的故障狀態(tài)診斷，零遮蓋閥的機(jī)械式零點(diǎn)調(diào)節(jié)，高強(qiáng)度，閥芯位置的位移反饋，可選擇閥芯位置行程監(jiān)控。Parker派克D*6FH系列先導(dǎo)式比例換向閥公稱尺寸為CET*P10至CETOP25（派克的廠內(nèi)標(biāo)準(zhǔn)）的D*6FH系列先導(dǎo)式連續(xù)調(diào)節(jié)的換向閥被用于控制和調(diào)節(jié)流量。該閥具有集成的電子元件，主級(jí)王的閥芯位置可調(diào)。與標(biāo)準(zhǔn)的閥相比集成的持續(xù)的差動(dòng)回路可提供更高的流量。典型的應(yīng)用是：流量控制極ng確和可實(shí)現(xiàn)流量調(diào)節(jié)，在快速/低速特性下的工作運(yùn)行帶有閥芯位置監(jiān)控例如：壓力機(jī)控制，動(dòng)態(tài)的位置調(diào)節(jié)和壓力/流量閉環(huán)系統(tǒng)調(diào)節(jié)。Parker派克先導(dǎo)式比例換向閥D*1FW/D*1FT系列公稱尺寸為CETOP5和CET*P10的D*1FW和D*1FT系列先導(dǎo)式比例換向閥被用于控制流量。該閥（D*1FW）采用PWD-400功率放大器進(jìn)行電控或?qū)⒓傻碾娮釉逖b在閥上組成一體（D*1FT）。典型的應(yīng)用是：通過調(diào)節(jié)斜坡信號(hào)可使閥芯柔和換向，以此來減小液壓和機(jī)械沖擊，通過電氣方式調(diào)節(jié)流量/速度可實(shí)現(xiàn)機(jī)械功能的自動(dòng)化。Parker派克先導(dǎo)式比例換向閥D*1FS系列公稱尺寸為CETOP3至CET*P10的D*1FS系列先導(dǎo)式比例換向閥被用于控制流量。該閥采用EW系列模擬式功率放大器進(jìn)行電控或采用VRD350/355數(shù)字式功率放大器。主閥芯的位置可調(diào)。典型的應(yīng)用是：流量控制極ng確和可實(shí)現(xiàn)流量調(diào)節(jié)，在快速/低速特性下的工作運(yùn)行和柔和加速度以及延遲工作特性的改善。Parker派克直動(dòng)式比例換向閥D*FW/D*FT系列公稱尺寸為CETOP3和CETOP5的直動(dòng)式（D*FW）換向閥系列是一種用于流量控制的比例閥。該閥（D*FW）采用PWD-400/PCD-400功率放大器進(jìn)行電控或?qū)⒓傻碾娮釉逖b在閥上組成一體（D*FT）。典型的應(yīng)用是：通過調(diào)節(jié)斜坡信號(hào)可使閥芯柔和換向，以此來減小液壓沖擊和機(jī)械沖擊，通過電氣方式調(diào)節(jié)流量/速度可實(shí)現(xiàn)機(jī)械功能自動(dòng)化。派克比例閥示例型號(hào)如下：D41FBB31FC4NS00D41FBB32FC1NKW0D41FBB32FC2NF00D41FBB32FC4NKW0D41FBE01FC1NF00D41FBE01FC4NJW0D41FBE02FC1NF00D41FHB01E1NE0047D41FHB31E1NE0044D41FHB31ElNE0047D41FHB31F1NE0040D41FHB32C1NB0D41FHB32C1NB00D41FHB32E2NB00D41FHB32F2NB00D41FHE01C2NB00D41FHE01E4VBOOD41FHE01F1NB0043D41FHE01F4NB0048D41FHE02C1NE00D41FIE01FC4NF0040D41FTB32FC1NFOOD41FTB32FC4VG00D41FTE01FCINF0040D41FTE01PC4NF0038D41FTE02FC4NF0038D41FTE01FC4NF0040D41FTE01SC4NF0040D41FWB00FC4NLWD1FPE50MH9NS0015D1FVE02BCVLW25D1FVE02BCVXW25D1FVE02BCVEOA38D1FVE02BCVF0040D1FVE02BCVF0A37D1FVE02BCVF0A38D1FVE02BCVF0A39D1FVE02BCVFOA38D1FVE02BCVG0AD1FVE02BCVLW25D1FVE02BCVLWX726D1FVE02BCVS0AD1FVE02BCVXW25D1FVE02CC0NM03D31FBB32EC1NS00D31FBB32EC2NF00D31FBB32EC2NS00D31FTE01CC1NF00(升級(jí)為_D31FBE01CC1NF00)D31FTE01CC1NG00(升級(jí)為_D31FBE01CC1NG00)D31FTE01CC2NF00(升級(jí)為_D31FBE01CC2NF00)D31FTE01CC4NF00(升級(jí)為_D31FBE01CC4NF00)D31FTE01CC4NG00(升級(jí)為_D31FBE01CC4NF00)D31FTE02CC4NG00(升級(jí)為_D31FBE02CC4NG00)D31FTE02CC4NF00(升級(jí)為_D31FBE02CC4NF00)D31FTE02CC4NS00(升級(jí)為D31FBE02CC4NS00）D31FTE02CC2NS00（升級(jí)為D31FBE02CC2NS00）D31FTE02CC2NF00（升級(jí)為D31FBE02CC2NF00）D31FTE02CC1NF00（升級(jí)為D31FBE02CC1NF00）D3FBB32MC0NF00D3FBB32MC0NS00D3FBE02MC0NF00D3FBE02MC0NG00D3FBE02MC0NS00D3FBE02SC0NKWD111FBB32LC2NF00D111FBB32LC2NG00D111FHB31L2NE00D111FHB31L2NB00D111FHE01H4NB00D111FHE01L4NB00D1FBB31FC0NS00D1FBB31FC0NF00D1FBE01FC0NF00D1FBE01HC0NF00D1FBE02FC0NF00D1FBE01KC0NJW3D1FBE01KC0NKW3D1FBE02KC0NJW3D1FBE02KC0NKW3D1FPE01BC9NB00D1FPE50FA9NB00D1FPE50FA9NS00D1FPE50FB9NB00D1FPE50FB9NS00D1FPE50HH9NB00D1FPE50HH9NS00D1FPE50MA9NS00D1FPE50MA9NB00D1FPE50MB9HE00X807D1FVE02BCVF0AD1FVE02BCVG0AD1FVE02CC0VF03D1FVE02BCVLBD1FVE02BCVLWD1FVE02BCVXWD1FVE50BCVLBD1FVE50BCVLBX826D1FVE50BCVLBX726D1FVE02BCVLWX726D3FBE02SC0VKW0D3FWE81MCNKW0D3FXE01HCNBJ00D3FXE01MCNBG00D3FXE01MCNBJ00D41FBB31FC1NF00D41FBB31FC1NG00D41FBB31FC2NF00D41FBB31FC4NF00D41FBB31FC4NG00D41FBB31FC4NM00D41FBB31FC4NS00D41FBB31FC5NS00D41FBB31FC5NW50D41FBB32CC1NS00D41FBB32CC4NF00D41FBB32FC1NF00D41FBB32FC1NS00D41FBB32FC2NF00D41FHB31E1NE00D41FHB31F1NE00D41FHB32C1NB00D41FHB32E2NB00D41FHB32F2NB00D41FHE01C1NE00D41FHE01C2NB00D41FHE01C4NB00D41FHE01E4VBOOD41FHE01F1NB00D41FHE01F4NB00D41FHE02C1NE00D41FTB32FC1NF00D41FTB32FC4VG00D41FTE01FC1NF00D41FTE01FC2NF00D41FTE01FC4NF00D41FTE01FCINF00D41FTE01PC4NF00D41FTE02FC1NF00D41FTE02FC4NF00D41FTEO1FC4NF00D41fteo1sc4nfooD81FHB32H1NE00D81FHB32H2NE00D81FHE01F1NE00D81FHE01F4NB00D91FBB31HC1NF00D91FBB32HC1NF00D91FBB32HC2NG00D91FBB32HC2NS00D91FBE02HC4NG00D91FBB32HC4VG00D91FBE01HC1VF00D91FBE01HC4VF00D91FBE01HC4VS00C10DFC101E80/0U9900D91FBE01HC4NKW0D91FHE01F1NE00D91FHE01H1NB00D91FHE02H1NB00D91FTB32HC1NG00D91FTB32HC2NG00D91FTB32HC4VGOD91FTE02HC4NG00D91FTE01HC1NF00D91FTE01HC4NF00D91FTE01HCINF00D91FTE02HC1NF00D91FTE02HC4NG00D111FBB32LC2NF0010D111FBB32LC2NG0010D111FHB31L2NE0048D111FHB31L2NB0048D111FHE01L4NB0048D1FBB31FC0NS0016D1FBB31FC0NF0016D1FBE01FC0NF0016D1FBE01HC0NF0016D1FBE02FC0NF0016D1FBE01KC0NJW314D1FBE01KC0NKW314D1FBE02KC0NJW314D1FBE02KC0NKW314D1FPE01BC9NB0020D1FPE50FA9NB0020D1FPE50FA9NS0020D1FPE50FB9NB0020D1FPE50FB9NS0020D1FPE50HH9NS0020D1FPE50MA9NS0020D1FPE50MA9NB0020D1FPE50MB9HE0020X807D1FVE02BCVF0A37D1FVE02BCVG0A37D1FVE02CC0VF0311D1FVE02BCVLB35D1FVE02BCVLW25D1FVE02BCVXW25D1FVE50BCVLB35D1FVE50BCVLB35X826D1FVE50BCVLB35X726PARKER派克比例閥D41FHE01C1型號(hào)下載[詳細(xì)]

  2018-10-06 10:02

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• 派克比例閥Z*技術(shù) 樣本D31FCE02DC1NB70

  派克已經(jīng)擴(kuò)大了其與D31FC系列集成數(shù)字電子設(shè)備的先導(dǎo)操作比例直流閥門系列。其特點(diǎn)是使用ParkerProPxD軟件的高精度位置反饋系統(tǒng)和簡(jiǎn)單的參數(shù)化。它提供了出色的性價(jià)比和經(jīng)濟(jì)可靠運(yùn)行的**條件。競(jìng)爭(zhēng)中的優(yōu)勢(shì)：在開發(fā)D31FC系列時(shí)，客戶的要求和愿望對(duì)于派克至關(guān)重要。其結(jié)果是：先導(dǎo)操作的控制閥具有強(qiáng)大的優(yōu)勢(shì)，為用戶提供了競(jìng)爭(zhēng)優(yōu)勢(shì)?？蛇x配EtherCAT：接口帶有EtherCAT的D*1FC？接口滿足閥門與主控之間現(xiàn)代通信的要求。由于數(shù)據(jù)傳輸速度高，循環(huán)周期短，因此現(xiàn)場(chǎng)總線系統(tǒng)中也可以實(shí)現(xiàn)苛刻的控制功能?！　　∨煽吮壤yD31FCE02DC1NB70特征：　逐行流量特性敏感調(diào)整　低滯后　高動(dòng)力　流量大　ZX位置監(jiān)控可選　節(jié)能A-再生可選　可切換混合版本可選　EtherCAT版本接口，2xM12x1連接器4針派克比例閥D31FCE02DC1NB70優(yōu)點(diǎn)：　適用于苛刻的開環(huán)應(yīng)用　改進(jìn)過程和產(chǎn)品精度　快速方便地參數(shù)化　出色的性價(jià)比　交貨時(shí)間短，無需存儲(chǔ)　原理圖：[詳細(xì)]

  2018-11-22 10:00

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• Parker派克全系列先導(dǎo)式比例閥資料下載

  Parker派克全系列先導(dǎo)式比例閥資料下載我公司專做歐美品牌，所有歐美品牌直接境外歐美國(guó)家采購(gòu)，本公司可以直接報(bào)關(guān)，貨期可以縮短一半，價(jià)格更有優(yōu)勢(shì)可以為您爭(zhēng)取更大的利潤(rùn)空間。如有需要請(qǐng)直接電話聯(lián)系或直接來本公司視察：以下品牌是我公司優(yōu)勢(shì)品牌：一：德國(guó)HAWE德國(guó)REXROTH德國(guó)FESTO德國(guó)BURKERT德國(guó)E+H德國(guó)西門子德國(guó)STAUFF西德福德國(guó)SCHMERSAL德國(guó)NEGELE耐格德國(guó)EMG（只做SV伺服閥系列）德國(guó)STEIMEL德國(guó)赫斯曼德國(guó)MURR德國(guó)HYADC德國(guó)P+F德國(guó)TURCK圖爾克德國(guó)SICK施克德國(guó)IFM博恩斯坦德國(guó)GSR德國(guó)PILZ德國(guó)MAHLE德國(guó)巴魯夫德國(guó)冬斯德國(guó)勞易測(cè)德國(guó)Linde林德德國(guó)COAX二:意大利ATOS意大利UNIVER意大利杰弗倫英國(guó)海隆諾冠意大利萬福樂法國(guó)高諾斯意大利康茂盛三:美國(guó)ASCOPARKER派克美國(guó)克力帕VICKERS威格士美國(guó)MOOG美國(guó)MAC美國(guó)紐曼帝克美國(guó)德威爾公司還有代理部分日本品牌（日本品牌直接辦事處采購(gòu)）如下：CKD喜開理，黑田精工，SUNX神視，TOYOOKI豐興，NACHI不二越，DAIKIN大金，KOGANEI小金井，TACO,NOK,東京美。【我公司可以自己進(jìn)口報(bào)關(guān)】Parker派克全系列先導(dǎo)式比例閥資料下載派克漢尼汾公司是yi流的運(yùn)動(dòng)控制制造公司，致力于提供yi流的產(chǎn)品及用戶服務(wù)。作為紐約證券交易所500強(qiáng)公司之一（紐約證交所交易代碼：PH），我們的元件和系統(tǒng)超過1400余條生產(chǎn)線，在運(yùn)動(dòng)控制方面分布于1000多個(gè)工業(yè)和航空領(lǐng)域。派克漢尼汾公司是**一家為客戶提供液壓、氣動(dòng)和機(jī)電一體化運(yùn)動(dòng)控制方案的制造商。公司在其領(lǐng)域內(nèi)擁有Zda的銷售網(wǎng)絡(luò)，有超過7500個(gè)銷售商在為世界各地400，000個(gè)客戶提供服務(wù)。派克漢尼汾進(jìn)入ZG已有二十多年的歷史，1990年派克漢尼汾公司在ZG建立了**個(gè)銷售辦事處。現(xiàn)共有四個(gè)銷售辦事處，分別位于上海、北京、廣州、香港。于1994年在香港成立了亞太地區(qū)總部。于2000年在金橋成立了獨(dú)資工廠，同時(shí)為ZG區(qū)的總部，即：派克漢尼汾管理（上海）有限公司，負(fù)責(zé)整個(gè)派克漢尼汾在ZG的管理。派克漢尼汾流體傳動(dòng)產(chǎn)品（上海）有限公司，作為銷售公司從事和發(fā)展派克ZG的業(yè)務(wù)活動(dòng)。就職于Parker并不僅僅是工作。作為科技產(chǎn)品和系統(tǒng)的制造商和設(shè)計(jì)商，Parker要依靠著公司雇員的支持、創(chuàng)新和多元化，始終無所畏懼地接受嚴(yán)峻挑戰(zhàn)。我們?yōu)橹鞠蜻h(yuǎn)大的高素質(zhì)人群-經(jīng)驗(yàn)豐富的專業(yè)人士以及應(yīng)屆畢業(yè)生-提供合適的職位和職業(yè)發(fā)展機(jī)會(huì)。Parker派克全系列先導(dǎo)式比例閥資料下載[詳細(xì)]

  2018-10-06 10:01

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• 現(xiàn)貨派克放大器PCD00A-400/**代理派克放大器

  現(xiàn)貨派克放大器PCD00A-400/**代理派克放大器美國(guó)派克放大器PCD00A-400PWDXXA-400PQDXXA-Z00現(xiàn)貨供應(yīng)D31FT系列為先導(dǎo)式比例方向控制閥，帶有內(nèi)置式的電子控制器，具有可調(diào)斜坡和遮蓋補(bǔ)償功能。D31FH/D41FH/D91FH/D111FH系列比例閥該系列為先導(dǎo)式比例換向閥，被用于控制流量，公稱尺寸為CETOP5-10。該閥具有集成的電子元件，主級(jí)的閥芯位置可調(diào)。典型的應(yīng)用是：流量控制極ng確和可實(shí)現(xiàn)流量調(diào)節(jié)，在快速/低速特性下的工作運(yùn)行帶有閥芯位置監(jiān)控，用于壓力機(jī)控制，動(dòng)態(tài)位置調(diào)節(jié)和壓力/流量閉環(huán)系統(tǒng)。技術(shù)特性泄漏量小高頻響，通油能力大準(zhǔn)確的故障狀態(tài)診斷零遮蓋閥的機(jī)械式零點(diǎn)調(diào)節(jié)高強(qiáng)度閥芯位置的位移反饋可選擇閥芯位置行程監(jiān)控常用的型號(hào)有：D31FBE01CC1NF00D31FTA31CC1NF00[詳細(xì)]

  2018-09-19 10:01

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• 派克齒輪泵技術(shù)資料

  派克齒輪泵技術(shù)資料派克齒輪泵是依靠泵缸與嚙合齒輪間所形成的工作容積變化和移動(dòng)來輸送液體或使之增壓的回轉(zhuǎn)泵。由兩個(gè)齒輪、泵體與前后蓋組成兩個(gè)封閉空間，當(dāng)齒輪轉(zhuǎn)動(dòng)時(shí)，齒輪脫開側(cè)的空間的體積從小變大，形成真空，將液體吸入，齒輪嚙合側(cè)的空間的體積從大變小，而將液體擠入管路中去。吸入腔與排出腔是靠?jī)蓚€(gè)齒輪的嚙合線來隔開的。派克齒輪泵的排出口的壓力完全取決于泵出處阻力的大小。派克齒輪泵優(yōu)點(diǎn)編輯派克齒輪采用具有國(guó)際九十年人先進(jìn)水平的新技術(shù)--雙圓弧正弦曲線齒型圓弧。它與漸開線齒輪相比，Z突出的優(yōu)點(diǎn)是齒輪嚙合過程中齒廓面沒有相對(duì)滑動(dòng)，所以齒面無磨損、運(yùn)轉(zhuǎn)平衡、無困液現(xiàn)象，噪聲低、壽命長(zhǎng)、效率高。該泵擺脫傳統(tǒng)設(shè)計(jì)的束縛，使得齒輪泵在設(shè)計(jì)、生產(chǎn)和使用上進(jìn)入了一個(gè)新的領(lǐng)域。派克齒輪泵設(shè)有差壓式安全閥作為超載保護(hù)，安全閥全回流壓力為泵額定排出壓力1.5倍。也可在允許排出壓力范圍內(nèi)根據(jù)實(shí)際需要另行調(diào)整。但是此安全閥不能作減壓閥長(zhǎng)期工作，需要時(shí)可在管路上另行安裝。該齒輪泵泵軸端密封設(shè)計(jì)為兩種形式，一種是機(jī)械密封，另一種是填料密封，可根據(jù)具體使用情況和用戶要求確定。派克齒輪泵缺點(diǎn)編輯困油現(xiàn)象派克齒輪泵要平穩(wěn)工作，齒輪嚙合的重合度必須大于1，于是總有兩對(duì)齒輪同時(shí)嚙合，并有一部分油液被圍困在兩對(duì)輪齒所圍成的封閉容腔之間。這個(gè)封閉的容腔開始隨著齒輪的轉(zhuǎn)動(dòng)逐漸減小，以后又逐漸加大。封閉腔容積的減小會(huì)使被困油液受擠壓而產(chǎn)生很高的壓力，并且從縫隙中擠出，導(dǎo)致油液發(fā)熱，并致使機(jī)件受到額外的負(fù)載；而封閉腔容積的增大又造成局部真空，使油液中溶解的氣體分離，產(chǎn)生氣穴現(xiàn)象。這些都將產(chǎn)生強(qiáng)烈的振動(dòng)和噪聲，這就是齒輪泵的困油現(xiàn)象。危害徑向不平衡力很大時(shí)能使軸彎曲，齒頂與殼體接觸，同時(shí)加速軸承的磨損，降低軸承的壽命。派克齒輪泵技術(shù)資料Parker派克PG系列齒輪泵（馬達(dá)）擁有以下三大類及多種型號(hào)可供選擇：一、300系列，鑄鐵殼體，型號(hào)：PGP/PGM315，PGP/PGM330，PGP/PGM350，PGP/PGM365.二、500系列，鋁合金殼體，型號(hào)：PGP/PGM503，PGP/PGM505，PGP/PGM511，PGP/PGM517.三、600系列，鑄鐵殼體，型號(hào)：PGP/PGM620.Parker齒輪泵系列：PGM031、PGM051、PGM075、PGM076、PGM315、PGM330、PGM350、PGM365、PGM502、PGM503、PGM505、PGM511、PGM517、PGM620、PGM640、PGP031、PGP050、PGP051、PGP315、PGP330、PGP350、PGP365、PGP502、PGP503、PGP505、PGP620、PGP640。Parker派克PX系列齒輪泵是一種性能先進(jìn)、采用國(guó)際流行“襯套單元"式樣的齒輪泵。PX系列齒輪泵性能優(yōu)良、效率高、高壓下工作噪聲低。該系列產(chǎn)品有4種規(guī)格P3X,P5X,P11X,P17X,排量范圍從0.8-52ml/rev。提供各種標(biāo)準(zhǔn)選項(xiàng)，來滿足范圍內(nèi)的應(yīng)用要求。其優(yōu)點(diǎn)有：1、高達(dá)4000psi/276bar連續(xù)工作：材料強(qiáng)度高、軸頸直徑大、軸承負(fù)載小、用于高壓下工作。2、噪聲低：13齒齒輪輪廓，優(yōu)化了的流量計(jì)量，減小壓力脈動(dòng)，運(yùn)行平穩(wěn)安靜。3、效率高：壓力平衡軸承單元確保在所有工況條件下達(dá)到ZGX率4、應(yīng)用靈活：國(guó)際認(rèn)可的安裝和連接形式、能夠安裝集成閥、公用進(jìn)油口的多聯(lián)泵配置，提供無可匹敵的應(yīng)用多功能性。GP和GPAN系列齒輪泵Parker派克GP和GPAN系列齒輪泵是用于開式回路的齒輪泵，壓鑄鋁殼體，流體靜壓間隙補(bǔ)償，滑動(dòng)軸承，單泵或多聯(lián)泵。此系列齒輪泵的特點(diǎn)有：高精加工的齒輪副。特殊的生產(chǎn)技術(shù)使彼此間的密封間隙Z小。用于靜壓間隙補(bǔ)償?shù)亩嗣鎵毫^(qū)域帶有密封件。通過選擇**的齒數(shù)使得泵的流量脈動(dòng)小并且噪音低。高壓采用用于高載荷的滑動(dòng)軸承采用壓鑄鋁的泵體使得泵的重量輕。排量為1.6-87.6ml/rev，額定壓力至230bar，Z高壓力可達(dá)270bar。GP/GP系列雙聯(lián)齒輪泵Parker派克GP/GP系列雙聯(lián)齒輪泵是由兩臺(tái)GP系列齒輪泵組合而成的雙聯(lián)泵。由于GP系列齒輪泵擁有多種型號(hào)可供選擇，所以由它組成的雙聯(lián)泵具有極其豐富的選擇，可以滿足各種不同需要。為了安全起見，所有多聯(lián)泵必須進(jìn)行許用總載荷的校核以避免傳動(dòng)軸過載。葉片泵Parker派克PVS系列變量葉片泵Parker派克PVS系列變量葉片泵為斜盤式結(jié)構(gòu)，其優(yōu)點(diǎn)有調(diào)節(jié)時(shí)間短，調(diào)節(jié)范圍寬，噪音低，效率高。排量為8-50ml/rev，出油口額定壓力為140bar，轉(zhuǎn)速范圍從1000-1800rpm，適應(yīng)油液溫度為-10至+70攝氏度。粘度范圍為22-100mm2/s。型號(hào)有：PVS08,PVS12,PVS16,PVS25,PVS32,PVS40,PVS50等。根據(jù)調(diào)節(jié)器功能不同，此系列變量葉片泵有PVS,PVY,PVD,PVH,PVM,PVK,PVL等。柱塞泵Parker派克PVM系列軸向柱塞泵Parker派克PVM系列軸向柱塞泵有帶標(biāo)準(zhǔn)壓力調(diào)節(jié)器和帶遙控壓力調(diào)節(jié)器兩種選擇。Zda排量從16至92ml/rev，額定工作壓力為250bar，Zdi轉(zhuǎn)速為每分鐘300轉(zhuǎn)，泄油口朝上。型號(hào)有：PVM016,PVM020,PVM023,PVM028,PVM032,PVM040,PVM046,PVM063,PVM080,PVM092等。PV系列軸向柱塞泵Parker派克PV系列軸向柱塞泵有帶標(biāo)準(zhǔn)壓力調(diào)節(jié)器和帶功率調(diào)節(jié)器兩種選擇。Zda排量從16至270ml/rev，額定工作壓力為350bar，Zdi轉(zhuǎn)速為每分鐘300轉(zhuǎn)，泄油口朝上。型號(hào)有：PV016,PV020,PV023,PV032,PV040,PV046,PV063,PV080,PV092,PV140,PV180,PV270等PAV6.3和PAV10系列軸向柱塞泵Parker派克PAV6.3和PAV10系列軸向柱塞泵為斜盤式變量柱塞泵，用于開式回路。單泵形式，調(diào)節(jié)器法蘭式連接于PAV6.3之上、螺紋擰入式連接于PAV10之上。連續(xù)工作壓力均為350barPV/GP系列雙聯(lián)泵Parker派克PV/GP系列雙聯(lián)泵是由一個(gè)PV系列軸向柱塞泵和一個(gè)GP系列齒輪泵組合而成，可以提供不同的排量組合。PV系列柱塞泵的Zda排量從16至270ml/rev，額定工作壓力為350bar，Zdi轉(zhuǎn)速為每分鐘300轉(zhuǎn)，泄油口朝上。GP系列齒輪泵的排量從1.6至7.9ml/rev，額定工作壓力至210bar。比例換向閥直動(dòng)式比例換向閥DFW/DFT系列公稱尺寸為CETOP3和CETOP5的直動(dòng)式（DFW）換向閥系列是一種用于流量控制的比例閥。該閥（DFW）采用PWD-400/PCD-400功率放大器進(jìn)行電控或?qū)⒓傻碾娮釉逖b在閥上組成一體（DFT）。典型的應(yīng)用是：通過調(diào)節(jié)斜坡信號(hào)可使閥芯柔和換向，以此來減小液壓沖擊和機(jī)械沖擊，通過電氣方式調(diào)節(jié)流量/速度可實(shí)現(xiàn)機(jī)械功能自動(dòng)化。直動(dòng)式比例換向閥DFL系列公稱尺寸為CETOP3和CETOP5的DFL系列的閥是一種用于流量控制的數(shù)字式比例閥。這種用微處理器控制的4-通閥可以通過配電信號(hào)來調(diào)出不同的給定速度。在閥上可以對(duì)加速度、減速度和速度進(jìn)行調(diào)節(jié)。典型的快速/低速行程特性可以不用其它的模塊就可實(shí)現(xiàn)。直動(dòng)式比例換向閥DFX系列派克齒輪泵技術(shù)資料[詳細(xì)]

  2018-09-07 10:00

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• 派克壓力控制器，SCPSD-060-14-15

  派克壓力控制器，SCPSD-060-14-15派克壓力傳感器，派克壓力開關(guān)SCP，派克壓力控制器SCPSD派克溫度控制器SCTSD，派克流量計(jì)SCQ，派克液位控制器SCLSD，派克電纜SCK派克數(shù)顯裝置SCE-020,派克轉(zhuǎn)換接頭SCA,派克溫度傳感器SCTparker壓力傳感器，parker壓力開關(guān)SCP，parker壓力控制器SCPSDparker溫度控制器SCTSD，parker流量計(jì)SCQ，parker液位控制器SCLSD，parker電纜SCKparker數(shù)顯裝置SCE-020,parker轉(zhuǎn)換接頭SCA,派parker溫度傳感器SCTSCP迷你型壓力器只包含少量零部件:傳感元件,信號(hào)處理集成電路和一個(gè)轉(zhuǎn)換開關(guān).特定用途集成電路ASIC是一種可編程的精密CMOS-ASIC,攜帶了EEPROM資料存儲(chǔ)器和模擬信號(hào)通道,適用溫度范圍很廣.由于電路校準(zhǔn)功能,因此傳感器的誤差很少,穩(wěn)定性很高,同時(shí)還能抗電磁干擾.壓力是由零起始點(diǎn)和長(zhǎng)斯穩(wěn)定的測(cè)量元件測(cè)量得出的.傳感器外殼采用的是密封式焊接不銹鋼,真空緊密性很好,同時(shí)具有防爆功能.其標(biāo)準(zhǔn)的G1/4BSPP連接螺紋采用防腐蝕不銹鋼材料,有很好介質(zhì)兼容性壓力控制器能夠適合各類工業(yè)現(xiàn)場(chǎng)，能夠理想的替代國(guó)外同類產(chǎn)品。且性能穩(wěn)定可靠精度:±0.5%重復(fù)性:±0.5.%結(jié)構(gòu)簡(jiǎn)單，無可拆卸部件SPDT或DPDT輸出;鑄鋁外殼(特殊外殼可訂做)，可選防爆;多種壓力及電氣接口可選量程:0~40Mpa可選。折疊技術(shù)規(guī)格測(cè)量介質(zhì):無腐蝕作用的氣體、液體或蒸汽等外殼:壓鑄鋁，環(huán)氧樹脂涂層，帶密封墊圈的外蓋設(shè)定點(diǎn)精度:±0.5%切換差:分為可調(diào)和不可調(diào)兩種(參考選型數(shù)據(jù)表)重復(fù)性誤差:<1%壓力接口:標(biāo)準(zhǔn)M20*1.5螺紋(可根據(jù)現(xiàn)場(chǎng)需要，特殊定制)電氣接口:M20*1.5螺紋接口(可根據(jù)現(xiàn)場(chǎng)需要，特殊定制)開關(guān)輸出:一個(gè)單刀雙擲(SPDT)輸出(開關(guān)可接"常開型"或者"常閉型")環(huán)境溫度;-40℃~+85℃(其他溫度可用遠(yuǎn)傳)環(huán)境濕度:5%~95%使用壽命:105次循環(huán)抗振性:<Max.2g外殼保護(hù)等級(jí):IP66派克壓力控制器，SCPSD-060-14-15SCP-250-24-07SCP-250-34-06SCP-250-34-07SCP-250-44-07SCP-400-24-06SCP-400-24-07SCP-400-34-06SCP-400-34-07SCP-600-14-06SCP-600-24-07SCP-600-44-06SCPSD-010-04-17SCPSD-016-04-16SCPSD-016-04-17SCPSD-016-14-17SCPSD-060-04-17SCPSD-100-04-17SCPSD-100-04-27SCPSD-100-14-15SCPSD-250-04-16SCPSD-250-04-17SCPSD-250-04-27SCPSD-250-14-15SCPSD-250-14-25SCPSD-400-04-17SCPSD-400-14-15SCPSD-600-14-15SCPT-015-02-02SCPT-060-02-02SCPT-1000-02-02SCPT-150-02-02SCPT-400-02-02SCPT-600-02-02SCQ-060-0-02SCQ-150-0-02SCRPM-210SCRPM-220SCRPMA-001SCRPMA-002SCSD-S27SCSN-100SCSN-450SCSW-KIT-400SCT-150-0-02SCT-150-04-02SCT-150-14-00SCTA-M10X1-ORSCTSD-150-00-06SCTSD-150-00-07SCTSD-150-10-05SCTSD-150-10-07SCTT-10-100-07SCTT-10-150-07SCTT-10-250-07SCVF-004-10-07SCVF-015SCVF-080SCVF-150-10-07SCVF-300-10-07SCVF-080-10-07SCVF-300-10-07SCFT-150-32-07SCM-152-2-02SCLTSD-520-00-07SCM-500-01-01SCP-060-34-07SCA-1/4-EMA-3CFSCA-1/4-EMA-3-SSCA-1/4-M22*1.5-EDSCA-7/14-EMA-3SCA-90-EMA-3SC-ACC-01SCK-400-10-45SCK-400-10-55SCP-600-24-06SCA-1/4-ED-1/2-EDSCP-600-24-06+SCA-1/4-ED-1/2-EDSCP-400-44-07+SCA-1/4-ED-1/2-EDSCP-400-44-07SCPSD-250-04-16SCPSD-250-04-27SCLTSD-370-10-07SCPSD-250-04-27SCK-410-03-45-45SCP-400-24-06SCK-155插頭SCJN-400-01SCPSD-100-14-05SCPSD-250-14-15SCPSD-600-14-05SCPSD-060-04-05SCPSD-060-04-17SCPSD-400-04-07SCPSD-400-14-17SCPSD-400-14-15SCPSD-250-14-17現(xiàn)貨SCPSD-010-04-17SCPSD-016-04-17SCP250-34-07SCPSD-250-04-17SCP-400-34-07SCP-400-24-07+SCK-155SCP-250-24-07SCP-100-34-07+SCK-155SCP-400-24-07SCP-600-44-06SCP-600-24-07SC-BAT-340SC-BAT-400SCC-340SCC-500SC-CD4082SCC-DRV-300SCE-020SCE-020-02SCE-025-01SCFT-015-02-02SCFT-015-C2-05SCFT-060-02-02SCFT-060-C2-05SCFT-150-02-02SCM-500-00-00SCM-500-01-00SCM-500-01-01SCMA-FCU-600SCMA-VADC-600SCP01-250-44-07SCP01-400-14-06SCP01-400-14-07SCP01-400-24-06SCP01-400-24-07SCP01-400-34-06SCP01-400-34-07SCP01-400-44-06SCP01-400-44-07SCP01-600-24-06SCP01-600-24-07SCP01-600-34-06SCP01-600-34-07SCP01-600-44-06SCP01-600-44-07SCP02-400-34-05SCP-060-B4-07-MOSCP-1000-34-06-EXSCP-250-34-06-EXSCP-250-34-07-UCCSCP-400-34-06-EXSCP-400-34-07-MOSCP-600-34-07-MOSCP-600-A4-07-MOSCP-9014SCP-9122SCP-9123SCP-9124SCP-9125SCPSD-004-04-17SCPSD-004-14-15SCPSD-004-14-25SCPSD-010-04-16SCPSD-010-04-17SCPSD-010-04-26SCPSD-400-04-26SCPSD-400-04-27SCPSD-400-14-15SCPSD-400-14-17SCPSD-400-14-25SCPSD-400-14-27SCPSD-600-04-16SCPSD-600-04-17SCPSD-600-14-15SCPSD-600-14-17SCPT-015-02-02SCPT-016-C2-05SCPT-060-02-02SCRPMA-002SCRPMA-010SCSD-PRG-KITSCSD-S27SCSN-410SCSN-450SCSW-400SCSW-KIT-152SCSW-KIT-400SCT-150-0-02SCT-150-04-02SCT-150-14-07SCT-400-K-01SCTA-400-02SCTSD-150-00-06SCTSD-150-00-07SCTSD-150-10-05SCTSD-150-10-07SCTSD-150-12-07SCTSD-250F-10-07SCTSD-L-165FS-215FO派克壓力控制器，SCPSD-060-14-15[詳細(xì)]

  2024-09-21 18:35

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• ATOS新型比例閥 ATOS比例閥

  ATOS新型比例閥，ATOS比例閥，阿托斯電磁閥，上海博嵐科技有限公司**代理銷售。ATOS新型比例閥，適用范圍廣，使用壽命長(zhǎng)，帶有雙位置傳感器，兩級(jí)比例閥，根據(jù)輸入電信號(hào)的大小提供方向控制和無壓力補(bǔ)償流量控制。比例閥與放大器配合工作，電子放大器對(duì)電磁閥提供適當(dāng)電流，以使電磁閥的調(diào)整量與電子放大器的輸入信號(hào)一致。此類閥為高性能閥，特別適用高動(dòng)態(tài)特性的位置或速度閉環(huán)控制回路。[詳細(xì)]

  2018-09-30 10:01

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• inspiralis2017Zxin價(jià)格表

  世界ding級(jí)實(shí)驗(yàn)材料供應(yīng)商QuickZyme正式授權(quán)上海起發(fā)為其ZG代理，QuickZyme在一直是行業(yè)的標(biāo)桿,一直為廣大科研客戶提供Z為優(yōu)質(zhì)的產(chǎn)品和服務(wù),上海起發(fā)一直秉承為ZG科研客戶帶來**的產(chǎn)品，**的服務(wù)，簽約QuickZyme就是為了給廣大科研客戶帶來更加完善的產(chǎn)品和服務(wù),您的滿意將是我們Zda的收獲QuickZymeZG代理,QuickZyme上海代理，QuickZyme北京代理，QuickZyme廣東代理，QuickZyme江蘇代理QuickZyme湖北代理,QuickZyme天津,QuickZyme黑龍江代理,QuickZyme內(nèi)蒙古代理,QuickZyme吉林代理,QuickZyme福建代理,QuickZyme江蘇代理,QuickZyme浙江代理,QuickZyme四川代理,QuickZymeBiosciencesisaninnovativelifesciencescompanyprovidingtheresearchcommunitywithnewanduniqueproductswithaddedvalueinthefieldofmatrixrelatedproteins,enzymesandassays.Itwasfoundedbyscientistswithalong-standingexperienceinassaydevelopmentandhasanexpertsscientificstaffcommittedtoassistinyourneedsinresearch.Customersatisfactionisourhighestpriority.QuickZymeBiosciencesisbasedattheBioSciencePark,Leiden,TheNetherlandsandhasaworldwidedistributornetwork.2017部分產(chǎn)品Zxin報(bào)價(jià)如下：貨號(hào)品名規(guī)格價(jià)格cas品牌QZBtotcol1totalcollagenassaykit96-assays1plate96assays49974-6周到貨QuickZyme2017QZBtotcol2totalcollagenassaykit2x96-assays2plates192assays94394-6周到貨QuickZyme2017QZBtotcol5totalcollagenassaykit5x96-assaysbulkpack5plates480assays186924-6周到貨QuickZyme2017QZBcol1-1solublecollagenassaykit96-assays1plate96assays49974-6周到貨QuickZyme2017QZBcol1-2solublecollagenassaykit2x96-assays2plates192assays94394-6周到貨QuickZyme2017QZBcol1-5solublecollagenassaykit5x96-assays5plates480assays186924-6周到貨QuickZyme2017QZBhypro1hydroxyprolineassaykit96-assays1plate96assays48124-6周到貨QuickZyme2017QZBhypro2hydroxyprolineassaykit2x96-assays2plates192assays90694-6周到貨QuickZyme2017QZBhypro5hydroxyprolineassaykit5x96-assaysbulkpack5plates480assays183224-6周到貨QuickZyme2017QZBtotprot1totalproteinassaykit96-assays1plate96assays42614-6周到貨QuickZyme2017QZBtotprot2totalproteinassaykit2x96-assays2plates192assays80604-6周到貨QuickZyme2017QZBtotprot5totalproteinassaykit5x96-assaysbulkpack5plates480assays159324-6周到貨QuickZyme2017QZBmmp2HhumanMMP-2activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZBmmp2Hv2humanMMP-2activityassaykit96-assaysversion21plate96assays81224-6周到貨QuickZyme2017QZBmmp2MmouseMMP-2activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZBmmp8HhumanMMP-8activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZBmmp9HhumanMMP-9activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZBmmp9MmouseMMP-9activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZMmmp7HhumanMMP-7activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZBmmp7MmouseMMP-7activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZBmmp14HhumanMMP-14activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZBGrB5humangranzymeBactivityassayreagentset5plates480assays123704-6周到貨QuickZyme2017QZBMR15-2-100Humanmannosereceptor(CD206)Mab100ugIgG39764-6周到貨QuickZyme2017QZBMR15-2-500Humanmannosereceptor(CD206)Mab500ugIgG114564-6周到貨QuickZyme2017QZBMMP9S22.2-100HumanMMP-9Mab100ugIgG41694-6周到貨QuickZyme2017QZBMMP9S22.2-500HumanMMP-9Mab500ugIgG120124-6周到貨QuickZyme2017QZBFBDDE2HumanfibrindegradationproductsplmgeneratedMab10ugIgG28754-6周到貨QuickZyme2017QZBFBDDE2HumanfibrindegradationproductsplmgeneratedMab100ugIgG43474-6周到貨QuickZyme2017QZBFBDDE2HumanfibrindegradationproductsplmgeneratedMab500ugIgG117564-6周到貨QuickZyme2017QZBFBDD13HumanfibrinfragmentD-dimerMab10ugIgG28754-6周到貨QuickZyme2017QZBFBDD13HumanfibrinfragmentD-dimerMab100ugIgG43474-6周到貨QuickZyme2017QZBFBDD13HumanfibrinfragmentD-dimerMab500ugIgG117564-6周到貨QuickZyme2017QZBFBY22HumanfibrinMab10ugIgG28754-6周到貨QuickZyme2017QZBFBY22HumanfibrinMab100ugIgG43474-6周到貨QuickZyme2017QZBFBY22HumanfibrinMab500ugIgG117564-6周到貨QuickZyme2017QZBFDP14-3-7Humanfibrin(ogen)degradationproductsMab10ugIgG28754-6周到貨QuickZyme2017QZBFDP14-3-7Humanfibrin(ogen)degradationproductsMab100ugIgG43474-6周到貨QuickZyme2017QZBFDP14-3-7Humanfibrin(ogen)degradationproductsMab500ugIgG117564-6周到貨QuickZyme2017QZBFBG8-1-2HumanintactfibrinogenMab10ugIgG28754-6周到貨QuickZyme2017QZBFBG8-1-2HumanintactfibrinogenMab100ugIgG43474-6周到貨QuickZyme2017QZBFBG8-1-2HumanintactfibrinogenMab500ugIgG117564-6周到貨QuickZyme2017QZBFBY18-4HumanfibrinogenMab10ugIgM28754-6周到貨QuickZyme2017QZBFBY18-4HumanfibrinogenMab100ugIgM43474-6周到貨QuickZyme2017QZBFBY18-4HumanfibrinogenMab500ugIgM117564-6周到貨QuickZyme2017我們公司Zda優(yōu)勢(shì)是強(qiáng)大的采購(gòu)，1：基本什么都能進(jìn)口，血清，抗體，耗材，還有部分限制進(jìn)口的，2：貨品全，現(xiàn)經(jīng)營(yíng)過700多個(gè)品牌，基本所有生物試劑耗材都可以進(jìn)口，特別是冷偏的產(chǎn)品那就更有優(yōu)勢(shì)，3：提供加急服務(wù)，一般1-2周到貨，超過時(shí)限加急費(fèi)全免4：價(jià)格公道，絕大部分價(jià)格有優(yōu)勢(shì)，當(dāng)然不能保證1**%產(chǎn)品都是價(jià)格Zdi,因?yàn)閮r(jià)格Zdi意味著沒有服務(wù).5：良好的信譽(yù)，大部分客戶我們提供貨到付款服務(wù)，客戶包括清華，北大交大復(fù)旦，中山等100多所大學(xué)，ROCHE，阿斯利康，國(guó)藥，fisher等500多家公司6：我們還是Santa,AdvancedBiotechnologiesInc,QuickZyme,bangs,BBInternational,QuickZyme,dianova,ezbiosystems,Inc.Dako,Inc,GePromegaridege,GlycotopeBiotechnologyGmbH;iduron,InnovativeResearchofAmerica,Ludger,neuroprobe,QuickZyme,QuickZyme,prospecbi,QuickZyme,progen,FULLERLABS,INC,sterlitech；SignalChem,QuickZymeBioTechnologies,Inc；worthington-biochem,QuickZyme等幾十家國(guó)外公司授權(quán)代理。7：我們還是invitrogen,qiagen,QuickZymeam,sigma;Promega,roche,merck,rnd,BD,GE,pierce,BioLegend等知名批發(fā)，歡迎合作。[詳細(xì)]

  2018-09-29 10:02

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• medicago2017Zxin價(jià)格表

  世界ding級(jí)實(shí)驗(yàn)材料供應(yīng)商QuickZyme正式授權(quán)上海起發(fā)為其ZG代理，QuickZyme在一直是行業(yè)的標(biāo)桿,一直為廣大科研客戶提供Z為優(yōu)質(zhì)的產(chǎn)品和服務(wù),上海起發(fā)一直秉承為ZG科研客戶帶來**的產(chǎn)品，**的服務(wù)，簽約QuickZyme就是為了給廣大科研客戶帶來更加完善的產(chǎn)品和服務(wù),您的滿意將是我們Zda的收獲QuickZymeZG代理,QuickZyme上海代理，QuickZyme北京代理，QuickZyme廣東代理，QuickZyme江蘇代理QuickZyme湖北代理,QuickZyme天津,QuickZyme黑龍江代理,QuickZyme內(nèi)蒙古代理,QuickZyme吉林代理,QuickZyme福建代理,QuickZyme江蘇代理,QuickZyme浙江代理,QuickZyme四川代理,QuickZymeBiosciencesisaninnovativelifesciencescompanyprovidingtheresearchcommunitywithnewanduniqueproductswithaddedvalueinthefieldofmatrixrelatedproteins,enzymesandassays.Itwasfoundedbyscientistswithalong-standingexperienceinassaydevelopmentandhasanexpertsscientificstaffcommittedtoassistinyourneedsinresearch.Customersatisfactionisourhighestpriority.QuickZymeBiosciencesisbasedattheBioSciencePark,Leiden,TheNetherlandsandhasaworldwidedistributornetwork.2017年部分產(chǎn)品Zxin報(bào)價(jià)如下：貨號(hào)品名規(guī)格價(jià)格cas品牌QZBtotcol1totalcollagenassaykit96-assays1plate96assays49974-6周到貨QuickZyme2017QZBtotcol2totalcollagenassaykit2x96-assays2plates192assays94394-6周到貨QuickZyme2017QZBtotcol5totalcollagenassaykit5x96-assaysbulkpack5plates480assays186924-6周到貨QuickZyme2017QZBcol1-1solublecollagenassaykit96-assays1plate96assays49974-6周到貨QuickZyme2017QZBcol1-2solublecollagenassaykit2x96-assays2plates192assays94394-6周到貨QuickZyme2017QZBcol1-5solublecollagenassaykit5x96-assays5plates480assays186924-6周到貨QuickZyme2017QZBhypro1hydroxyprolineassaykit96-assays1plate96assays48124-6周到貨QuickZyme2017QZBhypro2hydroxyprolineassaykit2x96-assays2plates192assays90694-6周到貨QuickZyme2017QZBhypro5hydroxyprolineassaykit5x96-assaysbulkpack5plates480assays183224-6周到貨QuickZyme2017QZBtotprot1totalproteinassaykit96-assays1plate96assays42614-6周到貨QuickZyme2017QZBtotprot2totalproteinassaykit2x96-assays2plates192assays80604-6周到貨QuickZyme2017QZBtotprot5totalproteinassaykit5x96-assaysbulkpack5plates480assays159324-6周到貨QuickZyme2017QZBmmp2HhumanMMP-2activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZBmmp2Hv2humanMMP-2activityassaykit96-assaysversion21plate96assays81224-6周到貨QuickZyme2017QZBmmp2MmouseMMP-2activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZBmmp8HhumanMMP-8activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZBmmp9HhumanMMP-9activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZBmmp9MmouseMMP-9activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZMmmp7HhumanMMP-7activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZBmmp7MmouseMMP-7activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZBmmp14HhumanMMP-14activityassaykit96-assays1plate96assays81224-6周到貨QuickZyme2017QZBGrB5humangranzymeBactivityassayreagentset5plates480assays123704-6周到貨QuickZyme2017QZBMR15-2-100Humanmannosereceptor(CD206)Mab100ugIgG39764-6周到貨QuickZyme2017QZBMR15-2-500Humanmannosereceptor(CD206)Mab500ugIgG114564-6周到貨QuickZyme2017QZBMMP9S22.2-100HumanMMP-9Mab100ugIgG41694-6周到貨QuickZyme2017QZBMMP9S22.2-500HumanMMP-9Mab500ugIgG120124-6周到貨QuickZyme2017QZBFBDDE2HumanfibrindegradationproductsplmgeneratedMab10ugIgG28754-6周到貨QuickZyme2017QZBFBDDE2HumanfibrindegradationproductsplmgeneratedMab100ugIgG43474-6周到貨QuickZyme2017QZBFBDDE2HumanfibrindegradationproductsplmgeneratedMab500ugIgG117564-6周到貨QuickZyme2017QZBFBDD13HumanfibrinfragmentD-dimerMab10ugIgG28754-6周到貨QuickZyme2017QZBFBDD13HumanfibrinfragmentD-dimerMab100ugIgG43474-6周到貨QuickZyme2017QZBFBDD13HumanfibrinfragmentD-dimerMab500ugIgG117564-6周到貨QuickZyme2017QZBFBY22HumanfibrinMab10ugIgG28754-6周到貨QuickZyme2017QZBFBY22HumanfibrinMab100ugIgG43474-6周到貨QuickZyme2017QZBFBY22HumanfibrinMab500ugIgG117564-6周到貨QuickZyme2017QZBFDP14-3-7Humanfibrin(ogen)degradationproductsMab10ugIgG28754-6周到貨QuickZyme2017QZBFDP14-3-7Humanfibrin(ogen)degradationproductsMab100ugIgG43474-6周到貨QuickZyme2017QZBFDP14-3-7Humanfibrin(ogen)degradationproductsMab500ugIgG117564-6周到貨QuickZyme2017QZBFBG8-1-2HumanintactfibrinogenMab10ugIgG28754-6周到貨QuickZyme2017QZBFBG8-1-2HumanintactfibrinogenMab100ugIgG43474-6周到貨QuickZyme2017QZBFBG8-1-2HumanintactfibrinogenMab500ugIgG117564-6周到貨QuickZyme2017QZBFBY18-4HumanfibrinogenMab10ugIgM28754-6周到貨QuickZyme2017QZBFBY18-4HumanfibrinogenMab100ugIgM43474-6周到貨QuickZyme2017我們公司Zda優(yōu)勢(shì)是強(qiáng)大的采購(gòu)，1：基本什么都能進(jìn)口，血清，抗體，耗材，還有部分限制進(jìn)口的，2：貨品全，現(xiàn)經(jīng)營(yíng)過700多個(gè)品牌，基本所有生物試劑耗材都可以進(jìn)口，特別是冷偏的產(chǎn)品那就更有優(yōu)勢(shì)，3：提供加急服務(wù)，一般1-2周到貨，超過時(shí)限加急費(fèi)全免4：價(jià)格公道，絕大部分價(jià)格有優(yōu)勢(shì)，當(dāng)然不能保證1**%產(chǎn)品都是價(jià)格Zdi,因?yàn)閮r(jià)格Zdi意味著沒有服務(wù).5：良好的信譽(yù)，大部分客戶我們提供貨到付款服務(wù)，客戶包括清華，北大交大復(fù)旦，中山等100多所大學(xué)，ROCHE，阿斯利康，國(guó)藥，fisher等500多家公司6：我們還是Santa,AdvancedBiotechnologiesInc,genebridge,bangs,BBInternational,crystalchem,dianova,FDNeurotechnologies,Inc.Dako,Inc,GePromegaridege,GlycotopeBiotechnologyGmbH;iduron,InnovativeResearchofAmerica,Ludger,neuroprobe,genebridge,Polysciences,prospecbi,QA-BIO,quickzyme,FULLERLABS,INC,sterlitech；sysy,TriLinkBioTechnologies,Inc；worthington-biochem,zyagen等幾十家國(guó)外公司授權(quán)代理。7：我們還是invitrogen,qiagen,genebridgeam,sigma;Promega,roche,merck,rnd,BD,GE,pierce,BioLegend等知名批發(fā)，歡迎合作。[詳細(xì)]

  2018-09-29 10:02

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• Emfret-2017Zxin價(jià)格表

  TocrisBioscience是高品質(zhì)試劑提供商，共有2000多種產(chǎn)品，主要集中在神經(jīng)科學(xué)和信號(hào)傳導(dǎo)領(lǐng)域，產(chǎn)品類型包括小分子、多肽、抗體、配體和化合物篩選文庫(kù)等，主要產(chǎn)品包括GPCRligands，神經(jīng)傳遞素，離子通道調(diào)控劑，信號(hào)通路YZ劑等，這些產(chǎn)品被廣泛選擇性地用于阻斷或激活生物學(xué)通路。2017年部分產(chǎn)品Zxin報(bào)價(jià)：品牌貨號(hào)品名規(guī)格目錄價(jià)格Tocris0101/100DL-AP4(100MG)100mg1,340Tocris0102/10D-AP4(10MG)10mg3,380Tocris0102/50D-AP4(50MG)50mg13,880Tocris0103/1L-AP4(1MG)1mg1,340Tocris0103/10L-AP4(10MG)10mg2,780Tocris0103/50L-AP4(50MG)50mg11,330Tocris0104/10DL-AP7(10MG)10mg1,730Tocris0104/50DL-AP7(50MG)50mg6,830Tocris0105/10DL-AP5(10MG)10mg1,130Tocris0105/50DL-AP5(50MG)50mg4,490Tocris0106/1D-AP5(1MG)1mg1,130Tocris0106/10D-AP5(10MG)10mg2,330Tocris0106/100D-AP5(100MG)100mg13,130Tocris0106/50D-AP5(50MG)50mg9,680Tocris0107/10L-AP5(10MG)10mg2,990Tocris0107/50L-AP5(50MG)50mg12,380Tocris0111/1Dihydrokainicacid(1MG)1mg1,190Tocris0111/10Dihydrokainicacid(10MG)10mg2,540Tocris0111/50Dihydrokainicacid(50MG)50mg10,580Tocris0112/50gDGG(50MG)50mg2,090Tocris0114/50NMDA(50MG)50mg1,340Tocris0114/500NMDA(500MG)500mg5,480Tocris0125/100DL-AP3(100MG)100mg1,730Tocris0162/10S-Sulfo-L-cysteinesodiumsalt(10MG)10mg2,840Tocris0162/50S-Sulfo-L-cysteinesodiumsalt(50MG)50mg11,480Tocris0169/10(RS)-AMPA(10MG)10mg2,840Tocris0169/50(RS)-AMPA(50MG)50mg11,480Tocris0173/10(RS)-CPP(10MG)10mg2,630Tocris0173/50(RS)-CPP(50MG)50mg10,580Tocris0178/10Phaclofen(10MG)10mg1,940Tocris0178/50Phaclofen(50MG)50mg8,030Tocris0180/10ZAPAsulfate(10MG)10mg1,880Tocris0180/50ZAPAsulfate(50MG)50mg8,030Tocris0181/10TACA(10MG)10mg1,730Tocris0181/50TACA(50MG)50mg7,280Tocris0183/10L-(-)-threo-3-Hydroxyasparticacid(10MG)10mg2,990Tocris0186/10cis-ACPD(10MG)10mg2,630Tocris0186/50cis-ACPD(50MG)50mg10,640Tocris0187/10trans-ACPD(10MG)10mg2,840Tocris0187/50trans-ACPD(50MG)50mg11,480Tocris0188/1L-Quisqualicacid(1MG)1mg1,340Tocris0188/10L-Quisqualicacid(10MG)10mg2,840Tocris0188/50L-Quisqualicacid(50MG)50mg11,480Tocris0189/10DNQX(10MG)10mg890Tocris0189/50DNQX(50MG)50mg2,780Tocris0190/10CNQX(10MG)10mg2,090Tocris0190/50CNQX(50MG)50mg8,780Tocris0197/10Homoquinolinicacid(10MG)10mg2,780Tocris0197/50Homoquinolinicacid(50MG)50mg11,330Tocris0205/1GL-Alanine(1G)1g890Tocris0206/1Gb-Alanine(1G)1g890Tocris0208/100Hypotaurine(100MG)100mg1,430Tocris0209/1GTaurine(1G)1g890Tocris0213/1GD-Asparticacid(1G)1g1,430Tocris0214/1GL-Asparticacid(1G)1g890Tocris0216/100L-Cysteinesulfinicacid(100MG)100mg1,730Tocris0217/1GD-Glutamicacid(1G)1g1,040Tocris0218/1GL-Glutamicacid(1G)1g890Tocris0219/1GGlycine(1G)1g890Tocris0222/1Kainicacid(1MG)1mg1,130Tocris0222/10Kainicacid(10MG)10mg2,330Tocris0222/50Kainicacid(50MG)50mg9,680Tocris0223/1GKynurenicacid(1G)1g1,130Tocris0225/1GQuinolinicacid(1G)1g1,130Tocris0226/1GD-Serine(1G)1g1,340Tocris0227/1GL-Serine(1G)1g890Tocris0234/100Guvacinehydrochloride(100MG)100mg2,630Tocris0235/100Isoguvacinehydrochloride(100MG)100mg2,990Tocris0236/100(+/-)-Nipecoticacid(100MG)100mg1,190Tocris0237/107-Chlorokynurenicacid(10MG)10mg1,190Tocris0237/507-Chlorokynurenicacid(50MG)50mg5,030Tocris0238/100O-Phospho-L-serine(100MG)100mg1,130Tocris0245/102-Hydroxysaclofen(10MG)10mg2,840Tocris0245/502-Hydroxysaclofen(50MG)50mg11,480Tocris0246/10Saclofen(10MG)10mg2,840Tocris0246/50Saclofen(50MG)50mg11,480Tocris0247/10(R)-CPP(10MG)10mg5,180Tocris0247/50(R)-CPP(50MG)50mg21,080Tocris0253/10(R)-AMPA(10MG)10mg4,490Tocris0254/1(S)-AMPA(1MG)1mg1,730Tocris0254/10(S)-AMPA(10MG)10mg3,830Tocris0254/50(S)-AMPA(50MG)50mg15,680Tocris0258/2CBC(25MG)25mg1,730Tocris0262/102,4-Dihydroxyphenylacetyl-L-asparagine(10MG)10mg2,990Tocris0262/502,4-Dihydroxyphenylacetyl-L-asparagine(50MG)50mg12,380Tocris0269/1Domoicacid(1MG)1mg2,480Tocris0269/5Domoicacid(5MG)5mg10,280Tocris0271/10cis-ACBD(10MG)10mg2,090Tocris0271/50cis-ACBD(50MG)50mg8,780Tocris0281/10(R)-(+)-HA-966(10MG)10mg2,090Tocris0282/10(S)-(-)-HA-966(10MG)10mg2,090Tocris0282/50(S)-(-)-HA-966(50MG)50mg8,780Tocris0284/10(1S,3R)-ACPD(10MG)10mg3,740Tocris0284/50(1S,3R)-ACPD(50MG)50mg15,380Tocris0286/105,7-Dichlorokynurenicacid(10MG)10mg1,340Tocris0286/505,7-Dichlorokynurenicacid(50MG)50mg5,180Tocris0290/250UN-(4-Hydroxyphenylacetyl)spermine(250UG)250ug2,090Tocris0298/10L-trans-2,4-PDC(10MG)10mg2,330Tocris0298/50L-trans-2,4-PDC(50MG)50mg9,680Tocris0307/10(S)-(-)-5-Iodowillardiine(10MG)10mg2,840Tocris0307/50(S)-(-)-5-Iodowillardiine(50MG)50mg11,480Tocris0310/10(RS)-4-Carboxy-3-hydroxyphenylglycine(10MG)10mg2,990Tocris0310/50(RS)-4-Carboxy-3-hydroxyphenylglycine(50MG)50mg12,380Tocris0312/10(RS)-(Tetrazol-5-yl)glycine(10MG)10mg2,990Tocris0312/50(RS)-(Tetrazol-5-yl)glycine(50MG)50mg12,380Tocris0320/10(S)-4-Carboxy-3-hydroxyphenylglycine(10MG)10mg4,940Tocris0320/50(S)-4-Carboxy-3-hydroxyphenylglycine(50MG)50mg20,180Tocris0321/10(RS)-4-Carboxyphenylglycine(10MG)10mg2,030Tocris0321/50(RS)-4-Carboxyphenylglycine(50MG)50mg8,540Tocris0322/10(R)-4-Carboxyphenylglycine(10MG)10mg4,040Tocris0322/50(R)-4-Carboxyphenylglycine(50MG)50mg16,580Tocris0323/10(S)-4-Carboxyphenylglycine(10MG)10mg4,040Tocris0323/50(S)-4-Carboxyphenylglycine(50MG)50mg16,580Tocris0324/10(RS)-3-Hydroxyphenylglycine(10MG)10mg2,030Tocris0324/50(RS)-3-Hydroxyphenylglycine(50MG)50mg8,540Tocris0326/10(S)-3-Hydroxyphenylglycine(10MG)10mg3,380Tocris0326/50(S)-3-Hydroxyphenylglycine(50MG)50mg13,880Tocris0328/10(R)-3-Carboxy-4-hydroxyphenylglycine(10MG)10mg5,540Tocris0328/50(R)-3-Carboxy-4-hydroxyphenylglycine(50MG)50mg22,490Tocris0329/10(S)-3-Carboxy-4-hydroxyphenylglycine(10MG)10mg5,540Tocris0329/50(S)-3-Carboxy-4-hydroxyphenylglycine(50MG)50mg22,490Tocris0332/10L-CCG-lll(10MG)10mg10,040Tocris0332/5L-CCG-lll(5MG)5mg5,930Tocris0333/10L-CCG-l(10MG)10mg7,130Tocris0336/10(RS)-MCPG(10MG)10mg2,090Tocris0336/50(RS)-MCPG(50MG)50mg8,780Tocris0337/10(S)-MCPG(10MG)10mg3,830Tocris0337/50(S)-MCPG(50MG)50mg15,680Tocris0341/10L-AP6(10MG)10mg3,590Tocris0341/50L-AP6(50MG)50mg14,780Tocris0342/1(RS)-3,5-DHPG(1MG)1mg980Tocris0342/10(RS)-3,5-DHPG(10MG)10mg2,090Tocris0342/50(RS)-3,5-DHPG(50MG)50mg8,780Tocris0344/1GGABA(1G)1g890Tocris0347/10nor-Binaltorphiminedihydrochloride(10MG)10mg2,390Tocris0347/50nor-Binaltorphiminedihydrochloride(50MG)50mg9,980Tocris0348/102-BFIhydrochloride(10MG)10mg2,090Tocris0348/502-BFIhydrochloride(50MG)50mg8,780Tocris0351/101-Acetyl-4-methylpiperazinehydrochloride(10MG)10mg1,880Tocris0351/501-Acetyl-4-methylpiperazinehydrochloride(50MG)50mg7,880Tocris0352/104-Acetyl-1,1-dimethylpiperaziniumiodide(10MG)10mg1,880Tocris0352/504-Acetyl-1,1-dimethylpiperaziniumiodide(50MG)50mg7,880Tocris0355/100(+/-)-Acetylcarnitinechloride(100MG)100mg1,130Tocris0357/10N-Acetyltryptamine(10MG)10mg1,730Tocris0357/50N-Acetyltryptamine(50MG)50mg7,280Tocris0360/10(+/-)-1-(1,2-Diphenylethyl)piperidinemaleate(10MG)10mg1,730Tocris0360/50(+/-)-1-(1,2-Diphenylethyl)piperidinemaleate(50MG)50mg7,280Tocris0361/10W-13hydrochloride(10MG)10mg2,090Tocris0361/50W-13hydrochloride(50MG)50mg8,780Tocris0368/10W-5hydrochloride(10MG)10mg2,090Tocris0369/100W-7hydrochloride(100MG)100mg1,940Tocris0370/10W-9hydrochloride(10MG)10mg2,030Tocris0370/50W-9hydrochloride(50MG)50mg8,540Tocris0373/10NBQX(10MG)10mg2,990Tocris0373/50NBQX(50MG)50mg12,380Tocris0378/10A-7hydrochloride(10MG)10mg1,730Tocris0379/10SKF97541(10MG)10mg2,630Tocris0379/50SKF97541(50MG)50mg10,640Tocris0380/10Y-25130hydrochloride(10MG)10mg2,390Tocris0380/50Y-25130hydrochloride(50MG)50mg9,980Tocris0383/10Arecaidinepropargylestertosylate(10MG)10mg1,430Tocris0383/50Arecaidinepropargylestertosylate(50MG)50mg5,990Tocris0384/10N-Acetyl-L-leucyl-L-leucyl-L-methional(10MG)10mg1,940Tocris0384/50N-Acetyl-L-leucyl-L-leucyl-L-methional(50MG)50mg8,030Tocris0386/103-Methyl-GABA(10MG)10mg1,940Tocris0386/503-Methyl-GABA(50MG)50mg8,030Tocris0387/1G(RS)-Atenolol(1G)1g1,130Tocris0389/50Arcainesulfate(50MG)50mg1,730Tocris0391/50Spaglumicacid(50MG)50mg2,090Tocris0393/10(S)-(-)-Atenolol(10MG)10mg1,580Tocris0393/50(S)-(-)-Atenolol(50MG)50mg6,290Tocris0395/10N-Acetylglycyl-D-glutamicacid(10MG)10mg1,490Tocris0395/50N-Acetylglycyl-D-glutamicacid(50MG)50mg6,290Tocris0396/10H-9dihydrochloride(10MG)10mg1,730Tocris0396/50H-9dihydrochloride(50MG)50mg7,280Tocris0405/10b-CCB(10MG)10mg1,580Tocris0405/50b-CCB(50MG)50mg6,680Tocris0411/10MDL73005EFhydrochloride(10MG)10mg2,090Tocris0411/50MDL73005EFhydrochloride(50MG)50mg8,780Tocris0412/10MDL72832hydrochloride(10MG)10mg2,090Tocris0412/50MDL72832hydrochloride(50MG)50mg8,780Tocris0414/10AG490(10MG)10mg1,640Tocris0414/50AG490(50MG)50mg6,890Tocris0415/50Ro20-1724(50MG)50mg1,130Tocris0416/10YS-035hydrochloride(10MG)10mg1,730Tocris0416/50YS-035hydrochloride(50MG)50mg7,280Tocris0420/10GBR13069dihydrochloride(10MG)10mg1,940Tocris0420/50GBR13069dihydrochloride(50MG)50mg8,030我們公司Zda優(yōu)勢(shì)是強(qiáng)大的采購(gòu)，1：基本什么都能進(jìn)口，血清，抗體，耗材，還有部分限制進(jìn)口的，2：貨品全，現(xiàn)經(jīng)營(yíng)過700多個(gè)品牌，基本所有生物試劑耗材都可以進(jìn)口，特別是冷偏的產(chǎn)品那就更有優(yōu)勢(shì)，3：提供加急服務(wù)，一般1-2周到貨，超過時(shí)限加急費(fèi)全免4：價(jià)格公道，絕大部分價(jià)格有優(yōu)勢(shì)，當(dāng)然不能保證1**%產(chǎn)品都是價(jià)格Zdi,因?yàn)閮r(jià)格Zdi意味著沒有服務(wù).5：良好的信譽(yù)，大部分客戶我們提供貨到付款服務(wù)，客戶包括清華，北大交大復(fù)旦，中山等100多所大學(xué)，ROCHE，阿斯利康，國(guó)藥，fisher等500多家公司6：我們還是Santa,AdvancedBiotechnologiesInc,Sorachim,bangs,BBInternational,crystalchem,dianova,FDNeurotechnologies,Inc.Dako,Inc,GePromegaridege,GlycotopeBiotechnologyGmbH;iduron,InnovativeResearchofAmerica,Ludger,neuroprobe,Sorachim,Polysciences,prospecbi,QA-BIO,quickzyme,FULLERLABS,INC,sterlitech；sysy,TriLinkBioTechnologies,Inc；worthington-biochem,zyagen等幾十家國(guó)外公司授權(quán)代理。7：我們還是invitrogen,qiagen,Sorachimam,sigma;Promega,roche,merck,rnd,BD,GE,pierce,BioLegend等知名批發(fā)，歡迎合作。[詳細(xì)]

  2018-09-29 10:02

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• FormuMax2017價(jià)格表

  FormuMaxScientific-脂質(zhì)體供應(yīng)專家FormuMaxScientific是一家位于加州北部硅谷ZX提供脂質(zhì)體給藥的專業(yè)公司，以滿足制藥、生物技術(shù)、化妝品及營(yíng)養(yǎng)企業(yè)日益增長(zhǎng)的研發(fā)需求。FormuMaxScientific力求成為脂質(zhì)體給藥領(lǐng)域的，特別是在配制用脂質(zhì)體及其他特定納米包埋傳輸?shù)膹?fù)雜藥物領(lǐng)域。在藥物傳輸企業(yè)，F(xiàn)ormuMaxScientific擁有由世界yi流專家領(lǐng)銜的技術(shù)團(tuán)隊(duì)，并致力于脂質(zhì)體及其它以磷脂為基礎(chǔ)的先進(jìn)藥物傳輸技術(shù)。FormuMax是目前**一家在線提供大量預(yù)制脂質(zhì)體試劑的公司，可為大學(xué)、研究所、研究ZX及各種研發(fā)企業(yè)提供優(yōu)質(zhì)的藥物傳輸試劑。同時(shí)該公司還可為基礎(chǔ)研究、配方可行性、定制配方制備、配方鑒定及分析提供全方位技術(shù)服務(wù)。FormuMax供應(yīng)主要產(chǎn)品：Clophosome-氯膦酸鹽脂質(zhì)體FormuMax提供兩種預(yù)埋有氯磷酸鹽分子的中性脂質(zhì)體產(chǎn)品，該產(chǎn)品單次靜脈或腹腔注射后可在經(jīng)巨噬細(xì)胞清除率可達(dá)80-90%，并具有高度活性、穩(wěn)定的理化性質(zhì)（長(zhǎng)期冰箱存放后仍保持均一性及懸浮特性），粘滯度低使用簡(jiǎn)便，適用于靜脈、腹腔、皮下、鼻腔、氣管等多種方式給藥。Doxoves-鹽酸多柔比星脂質(zhì)體FormuMax可提供脂質(zhì)定制的鹽酸多柔比星脂質(zhì)體（定制內(nèi)容為脂質(zhì)成分及脂質(zhì)體大?。?。FormuMax提供的產(chǎn)品為Doxoves，具有高度的產(chǎn)品穩(wěn)定性和一致性,緊密的粒徑分布和GX的藥物包埋效率（高達(dá)4.0mg/mL(40mMlipid)的包埋藥物濃度）。Doxoves系列產(chǎn)品在產(chǎn)品特性、穩(wěn)定性及藥代動(dòng)力學(xué)特性上可媲美商業(yè)產(chǎn)品Doxil。DrugLoadedLiposomesFormuMax提供多款包埋活性藥物的脂質(zhì)體產(chǎn)品，包括DoxorubicinHCl（含2.0mg/mL及4.0mg/mL兩種濃度），IrinotecanHCl(2.0mg/mL)，TopotecanHCl(2.0mg/mL)，產(chǎn)品線仍在持續(xù)更新中。預(yù)制脂質(zhì)體FormuMax供應(yīng)的預(yù)制脂質(zhì)體產(chǎn)品囊括多種通用的脂質(zhì)體類型，使用世界yi流的優(yōu)質(zhì)脂類原料。該系列產(chǎn)品易于使用，穩(wěn)定性、可靠性及可重復(fù)性高，節(jié)省時(shí)間和成本，并可為研究人員提供定制脂質(zhì)體服務(wù)。目前FormuMax提供聚乙二醇化/非聚乙二醇化的常用脂質(zhì)體，以及含濃度梯度Ammonium的脂質(zhì)體陽(yáng)離子脂質(zhì)體FormuMax供應(yīng)一系列的陽(yáng)離子脂質(zhì)體，用于需帶正電荷的脂質(zhì)體或細(xì)胞轉(zhuǎn)染質(zhì)粒DNA、反義/干擾RNA等。熒光脂質(zhì)體FormuMax供應(yīng)預(yù)制熒光標(biāo)記的脂質(zhì)體，包括常規(guī)熒光脂質(zhì)體、生物素化的熒光脂質(zhì)體以及Avdinized化的熒光脂質(zhì)體，另外還提供客戶定制的熒光脂質(zhì)體（脂類及染料可選）。脂質(zhì)體制備薄膜FormuMax供應(yīng)一系列不同規(guī)格的聚碳酸酯薄膜，用于脂質(zhì)體擠出制備。部分產(chǎn)品Zxin報(bào)價(jià)：貨號(hào)品名規(guī)格（ML)價(jià)格F90101TH-05Trans-Hi-InvitroTransfectionReagent0.52193newF90101TH-10Trans-Hi-InvitroTransfectionReagent13893newF90101TH-101Trans-Hi-InvitroTransfectionReagent10x1.0mL28883newF90101TH-00freeevaluationsample,Trans-Hi-InvitroTransfectionReagent(50l)0.05850F10102PlainDPPC/CHOLLiposomes(55:45mol/mol,100nm,60mM)108483F10103PlainDSPC/CHOLLiposomes(55:45mol/mol,100nm,60mM)105933F10104PlainHSPC/CHOLLiposomes(55:45mol/mol,100nm,60mM)105083F10105Plain20:0PC/CHOLLiposomes(55:45mol/mol,100nm,60mM)108483F10109PlainPureDOPCLiposomes(100nm,60mM)106103F10110PlainPurePOPCLiposomes(100nm,60mM)107123F10202PlainDPPC/CHOL/mPEG2000-DSPELiposomes(50:45:5mol/mol,100nm,60mM)109333F10203PlainDSPC/CHOL/mPEG2000-DSPELiposomes(50:45:5mol/mol,100nm,60mM)107123F10204PlainHSPC/CHOL/mPEG2000-DSPELiposomes(50:45:5mol/mol,100nm,60mM)106443F10205Plain20:0PC/CHOL/mPEG2000-DSPELiposomes(50:45:5mol/mol,100nm,60mM)109333F20103ADSPC/CHOL(55:45mol/mol)LiposomeswithAmmoniumGradient(100nm)109503F20104AHSPC/CHOL(55:45mol/mol)LiposomeswithAmmoniumGradient(100nm)108993F20203ADSPC/CHOL/mPEG-DSPE(50:45:5mol/mol)LiposomeswithAmmoniumGradient(100nm)1010183F20204AHSPC/CHOL/mPEG2000-DSPE(50:45:5mol/mol)LiposomeswithAmmoniumGradient(100nm)109333F20204ABHSPC/CHOL/mPEG2000-DSPE(56.2/38.5/5.3)LiposomeswithAmmoniumGradient(100nm)1010013F20204ASSUVHSPC/CHOL/mPEG2000-DSPE(56.2/38.5/5.3)LiposomeswithAmmoniumGradient(80nm)1011883F30204B-D2-2Doxoves-STEALTHLiposomalDoxorubicinHCl(2.0mg/mL)25083newF30204B-D2-10Doxoves-STEALTHLiposomalDoxorubicinHCl(2.0mg/mL)1016983newF30204B-C2-2ControlliposomesforDoxoves(20mM)22533newF30204B-C2-10ControlliposomesforDoxoves(20mM)108483newF30204C-D2-2CombokitofDoxoves(2.0mg/mL)ControlliposomesforDoxoves(20mM)26783newF30204C-D2-10CombokitofDoxoves(2.0mg/mL)ControlliposomesforDoxoves(20mM)1022933newF30204B-D-2Doxoves-STEALTHLiposomalDoxorubicinHCl(4.0mg/mL)27973F30204B-D-10Doxoves-STEALTHLiposomalDoxorubicinHCl(4.0mg/mL)1027183F30204C-D-2CombokitofDoxovesandplaincontrolliposomes210523F30204C-D-10CombokitofDoxovesandplaincontrolliposomes1036703F30204B-C-2ControlliposomesforDoxoves(40mM)23213F30204B-C-10ControlliposomesforDoxoves(40mM)1013073F30204-IT-2STEALTHLiposomalIrinotecanHCl(2.0mg/mL,80-100nm)213583F30204-TT-2STEALTHLiposomalTopotecanHCl(2.0mg/mL,80-100nm)213583FB30020DilutionBufferforDoxoves201003F50101CationicLiposomesDMTAP/DOPE24913F50102CationicLiposomesDOTAP/DOPE23723F50103CationicLiposomesDDAB/DOPE23893F50104CationicLiposomesDODAP/DOPE24063F50105CationicLiposomesDC-CHOL/DOPE24063F60103-PPlaceboControlforfluorescentDOPC/CHOLLiposomes13043F60103F-DDOPC/CHOLLiposomeslabeledwithdansylDOPE16783F60103F-FDOPC/CHOLLiposomeslabeledwithFluoresceinDHPE15593F60103F-MBDOPC/CHOLLiposomeslabeledwithMarinaBlue-DHPE19673F60103F-NBDDOPC/CHOLLiposomesLabeledwithNBD-PE15593F60103F-OGDOPC/CHOLLiposomeslabeledwithOregonGreen488DHPE17463F60103F-RDOPC/CHOLLiposomeslabeledwithRhodamineDHPE15593F60103F-TCDOPC/CHOLLiposomeslabeledwithTRITC-DHPE17463F60103F-TRDOPC/CHOLLiposomeslabeledwithTexasRedDHPE17463F60103F-DIDOPC/CHOLLiposomeslabeledwithDiI14403F60103F-DADOPC/CHOLLiposomeslabeledwithDiA14913F60103F-DO-1DOPC/CHOLLiposomeslabeledwithDiO14743F60103F-DRDOPC/CHOLLiposomeslabeledwithDiR15083F60103F-DDDOPC/CHOLLiposomeslabeledwithDiD14913F60203F-DDOPC/CHOL/mPEG-DSPELiposomesLabeledwithDansylDOPE17123F60203F-FDOPC/CHOL/mPEG-DSPELiposomeslabeledwithFluoresceinDHPE16443F60203F-MBDOPC/CHOL/mPEG-DSPELiposomeslabeledwithMarinaBlue-DHPE19333F60203F-NBDDOPC/CHOL/mPEG-DSPELiposomesLabeledwithNBD-PE18483F60203F-OGDOPC/CHOL/mPEG-DSPELiposomeslabeledwithOregonGreen488DHPE18483F60203F-RDOPC/CHOL/mPEG2000-DSPELiposomeslabeledwithRhodamineDHPE16613F60203F-TCDOPC/CHOL/mPEG-DSPELiposomeslabeledwithTRITC-DHPE18313F60203F-TRDOPC/CHOL/mPEG-DSPELiposomeslabeledwithTexasRedDHPE18483F60203-PPlaceboControlDOPC/CHOL/PEG-DSPELiposomes13383F60203F-DDPEGylatedDOPC/CHOL/mPEG-PELiposomeslabeledwithDiD15593F60203F-DAPEGylatedDOPC/CHOLLiposomeslabeledwithDiA15593F60203F-DIPEGylatedDOPC/CHOLLiposomeslabeledwithDiI15083F60203F-DRPEGylatedDOPC/CHOLLiposomeslabeledwithDiR15763F60203F-DOPEGylatedDOPC/CHOLLiposomeslabeledwithDiO15423F60103F2-PPlaceboControlDOPC/CHOLLiposomes(200nm)forFluorescentliposomes14233newF60103F2-FFluorescentDOPC/CHOLLiposomeslabeledwithFluoresceinDHPE(200nm)16443newF60103F2-RFluorescentDOPC/CHOLLiposomeslabeledwithRhodamineDHPE(200nm)15933newF60103F2-TRFluorescentDOPC/CHOLLiposomeslabeledwithTexasRed488DHPE(200nm)17973newF70101C-NASEvaluationSamples:Clophosome(neutral)andClophosome-A(anionic)USA1700F70101C-N-2Clophosome,ClodronateLiposomes(Neutral)23383F70101C-N-10Clophosome,ClodronateLiposomes(Neutral)1011883F70101-N-2PlainControlLiposomesforClophosome(Neutral)21683F70101-N-10PlainControlLiposomesforClophosome(Neutral)105933F70101F-N-2FluorescentControlLiposomesforClophosome(neutral)22533F70101F-N-10FluorescentControlLiposomesforClophosome(neutral)108823F70101C-NC-2Combo:Clophosome-N(neutral)andControlLiposomes24063F70101C-NC-10Combo:Clophosome-N(neutral)andControlLiposomes1014263F70101C-NF-2Combo:Clophosome-N(neutrral),Fluorescent&PlainControlLiposomes26103F70101C-NF-10Combo:Clophosome-N(neutrral),Fluorescent&PlainControlLiposomes1022933F70101C-A-2Clophosome-A-ClodronateLiposomes(Anionic)25083F70101C-A-10Clophosome-A-ClodronateLiposomes(Anionic)1017833F70101-A-2PlainControlLiposomesforClophosome-A(Anionic)22533F70101-A-10PlainControlLiposomesforClophosome-A(Anionic)108823F70101F-A-2FluorescentControlLiposomesforClophosome-A(anionic)23383F70101F-A-10FluorescentControlLiposomesforClophosome-A(anionic)1011883F70101C-AC-2Combo:Clophosome-AandControlLiposomes25933F70101C-AC-10Combo:Clophosome-AandControlLiposomes1020723F70101C-AF-2Clophosome-A,Fluorescent&PlainControlLiposomes28823F70101C-AF-10Clophosome-A,Fluorescent&PlainControlLiposomes1034323F70101C-NA-2All-In-OneComboKit:Clophosome-A(anionic),Clophosome-N(neutral)-AndControlLiposomesforboth210183F70101C-NA-10All-In-OneComboKit:Clophosome-A(anionic),Clophosome-N(neutral)-AndControlLiposomesforboth1035683F70101C-NHHighPotencyClophosome-ClodronateLiposomes(Neutral,1.0mL,20mg/mL)18483newF1N5119PolycarbonateMembraneFilter(19mm,0.05um)12533newF1N8119PolycarbonateMembraneFilter(19mm,0.08um)12533newF1N10119PolycarbonateMembraneFilter(19mm,0.1um)11581newF1N20119PolycarbonateMembraneFilter(19mm,0.2um)11173newF1N40119PolycarbonateMembraneFilter(25mm,0.4um)11173newF1M10119PolycarbonateMembraneFilter(19mm,1.0um)11190newF1N5125PolycarbonateMembraneFilter(25mm,0.05um)12040newF1N8125PolycarbonateMembraneFilter(25mm,0.08um)11955newF1N10125PolycarbonateMembraneFilter(25mm,0.1um)11666newF1N20125PolycarbonateMembraneFilter(25mm,0.2um)11037newF1N40125PolycarbonateMembraneFilter(25mm,0.4um)11088newF1M10125PolycarbonateMembraneFilter(25mm,1.0um)11275[詳細(xì)]

  2018-09-29 10:02

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• Chem-ImpexZxin價(jià)格表

  FormuMaxScientific-脂質(zhì)體供應(yīng)專家FormuMaxScientific是一家位于加州北部硅谷ZX提供脂質(zhì)體給藥的專業(yè)公司，以滿足制藥、生物技術(shù)、化妝品及營(yíng)養(yǎng)企業(yè)日益增長(zhǎng)的研發(fā)需求。FormuMaxScientific力求成為脂質(zhì)體給藥領(lǐng)域的，特別是在配制用脂質(zhì)體及其他特定納米包埋傳輸?shù)膹?fù)雜藥物領(lǐng)域。在藥物傳輸企業(yè)，F(xiàn)ormuMaxScientific擁有由世界yi流專家領(lǐng)銜的技術(shù)團(tuán)隊(duì)，并致力于脂質(zhì)體及其它以磷脂為基礎(chǔ)的先進(jìn)藥物傳輸技術(shù)。FormuMax是目前**一家在線提供大量預(yù)制脂質(zhì)體試劑的公司，可為大學(xué)、研究所、研究ZX及各種研發(fā)企業(yè)提供優(yōu)質(zhì)的藥物傳輸試劑。同時(shí)該公司還可為基礎(chǔ)研究、配方可行性、定制配方制備、配方鑒定及分析提供全方位技術(shù)服務(wù)。FormuMax供應(yīng)主要產(chǎn)品：Clophosome-氯膦酸鹽脂質(zhì)體FormuMax提供兩種預(yù)埋有氯磷酸鹽分子的中性脂質(zhì)體產(chǎn)品，該產(chǎn)品單次靜脈或腹腔注射后可在經(jīng)巨噬細(xì)胞清除率可達(dá)80-90%，并具有高度活性、穩(wěn)定的理化性質(zhì)（長(zhǎng)期冰箱存放后仍保持均一性及懸浮特性），粘滯度低使用簡(jiǎn)便，適用于靜脈、腹腔、皮下、鼻腔、氣管等多種方式給藥。Doxoves-鹽酸多柔比星脂質(zhì)體FormuMax可提供脂質(zhì)定制的鹽酸多柔比星脂質(zhì)體（定制內(nèi)容為脂質(zhì)成分及脂質(zhì)體大?。ormuMax提供的產(chǎn)品為Doxoves，具有高度的產(chǎn)品穩(wěn)定性和一致性,緊密的粒徑分布和GX的藥物包埋效率（高達(dá)4.0mg/mL(40mMlipid)的包埋藥物濃度）。Doxoves系列產(chǎn)品在產(chǎn)品特性、穩(wěn)定性及藥代動(dòng)力學(xué)特性上可媲美商業(yè)產(chǎn)品Doxil。DrugLoadedLiposomesFormuMax提供多款包埋活性藥物的脂質(zhì)體產(chǎn)品，包括DoxorubicinHCl（含2.0mg/mL及4.0mg/mL兩種濃度），IrinotecanHCl(2.0mg/mL)，TopotecanHCl(2.0mg/mL)，產(chǎn)品線仍在持續(xù)更新中。預(yù)制脂質(zhì)體FormuMax供應(yīng)的預(yù)制脂質(zhì)體產(chǎn)品囊括多種通用的脂質(zhì)體類型，使用世界yi流的優(yōu)質(zhì)脂類原料。該系列產(chǎn)品易于使用，穩(wěn)定性、可靠性及可重復(fù)性高，節(jié)省時(shí)間和成本，并可為研究人員提供定制脂質(zhì)體服務(wù)。目前FormuMax提供聚乙二醇化/非聚乙二醇化的常用脂質(zhì)體，以及含濃度梯度Ammonium的脂質(zhì)體陽(yáng)離子脂質(zhì)體FormuMax供應(yīng)一系列的陽(yáng)離子脂質(zhì)體，用于需帶正電荷的脂質(zhì)體或細(xì)胞轉(zhuǎn)染質(zhì)粒DNA、反義/干擾RNA等。熒光脂質(zhì)體FormuMax供應(yīng)預(yù)制熒光標(biāo)記的脂質(zhì)體，包括常規(guī)熒光脂質(zhì)體、生物素化的熒光脂質(zhì)體以及Avdinized化的熒光脂質(zhì)體，另外還提供客戶定制的熒光脂質(zhì)體（脂類及染料可選）。脂質(zhì)體制備薄膜FormuMax供應(yīng)一系列不同規(guī)格的聚碳酸酯薄膜，用于脂質(zhì)體擠出制備。部分產(chǎn)品Zxin報(bào)價(jià)：貨號(hào)品名規(guī)格（ML)價(jià)格F90101TH-05Trans-Hi-InvitroTransfectionReagent0.52193newF90101TH-10Trans-Hi-InvitroTransfectionReagent13893newF90101TH-101Trans-Hi-InvitroTransfectionReagent10x1.0mL28883newF90101TH-00freeevaluationsample,Trans-Hi-InvitroTransfectionReagent(50l)0.05850F10102PlainDPPC/CHOLLiposomes(55:45mol/mol,100nm,60mM)108483F10103PlainDSPC/CHOLLiposomes(55:45mol/mol,100nm,60mM)105933F10104PlainHSPC/CHOLLiposomes(55:45mol/mol,100nm,60mM)105083F10105Plain20:0PC/CHOLLiposomes(55:45mol/mol,100nm,60mM)108483F10109PlainPureDOPCLiposomes(100nm,60mM)106103F10110PlainPurePOPCLiposomes(100nm,60mM)107123F10202PlainDPPC/CHOL/mPEG2000-DSPELiposomes(50:45:5mol/mol,100nm,60mM)109333F10203PlainDSPC/CHOL/mPEG2000-DSPELiposomes(50:45:5mol/mol,100nm,60mM)107123F10204PlainHSPC/CHOL/mPEG2000-DSPELiposomes(50:45:5mol/mol,100nm,60mM)106443F10205Plain20:0PC/CHOL/mPEG2000-DSPELiposomes(50:45:5mol/mol,100nm,60mM)109333F20103ADSPC/CHOL(55:45mol/mol)LiposomeswithAmmoniumGradient(100nm)109503F20104AHSPC/CHOL(55:45mol/mol)LiposomeswithAmmoniumGradient(100nm)108993F20203ADSPC/CHOL/mPEG-DSPE(50:45:5mol/mol)LiposomeswithAmmoniumGradient(100nm)1010183F20204AHSPC/CHOL/mPEG2000-DSPE(50:45:5mol/mol)LiposomeswithAmmoniumGradient(100nm)109333F20204ABHSPC/CHOL/mPEG2000-DSPE(56.2/38.5/5.3)LiposomeswithAmmoniumGradient(100nm)1010013F20204ASSUVHSPC/CHOL/mPEG2000-DSPE(56.2/38.5/5.3)LiposomeswithAmmoniumGradient(80nm)1011883F30204B-D2-2Doxoves-STEALTHLiposomalDoxorubicinHCl(2.0mg/mL)25083newF30204B-D2-10Doxoves-STEALTHLiposomalDoxorubicinHCl(2.0mg/mL)1016983newF30204B-C2-2ControlliposomesforDoxoves(20mM)22533newF30204B-C2-10ControlliposomesforDoxoves(20mM)108483newF30204C-D2-2CombokitofDoxoves(2.0mg/mL)ControlliposomesforDoxoves(20mM)26783newF30204C-D2-10CombokitofDoxoves(2.0mg/mL)ControlliposomesforDoxoves(20mM)1022933newF30204B-D-2Doxoves-STEALTHLiposomalDoxorubicinHCl(4.0mg/mL)27973F30204B-D-10Doxoves-STEALTHLiposomalDoxorubicinHCl(4.0mg/mL)1027183F30204C-D-2CombokitofDoxovesandplaincontrolliposomes210523F30204C-D-10CombokitofDoxovesandplaincontrolliposomes1036703F30204B-C-2ControlliposomesforDoxoves(40mM)23213F30204B-C-10ControlliposomesforDoxoves(40mM)1013073F30204-IT-2STEALTHLiposomalIrinotecanHCl(2.0mg/mL,80-100nm)213583F30204-TT-2STEALTHLiposomalTopotecanHCl(2.0mg/mL,80-100nm)213583FB30020DilutionBufferforDoxoves201003F50101CationicLiposomesDMTAP/DOPE24913F50102CationicLiposomesDOTAP/DOPE23723F50103CationicLiposomesDDAB/DOPE23893F50104CationicLiposomesDODAP/DOPE24063F50105CationicLiposomesDC-CHOL/DOPE24063F60103-PPlaceboControlforfluorescentDOPC/CHOLLiposomes13043F60103F-DDOPC/CHOLLiposomeslabeledwithdansylDOPE16783F60103F-FDOPC/CHOLLiposomeslabeledwithFluoresceinDHPE15593F60103F-MBDOPC/CHOLLiposomeslabeledwithMarinaBlue-DHPE19673F60103F-NBDDOPC/CHOLLiposomesLabeledwithNBD-PE15593F60103F-OGDOPC/CHOLLiposomeslabeledwithOregonGreen488DHPE17463F60103F-RDOPC/CHOLLiposomeslabeledwithRhodamineDHPE15593F60103F-TCDOPC/CHOLLiposomeslabeledwithTRITC-DHPE17463F60103F-TRDOPC/CHOLLiposomeslabeledwithTexasRedDHPE17463F60103F-DIDOPC/CHOLLiposomeslabeledwithDiI14403F60103F-DADOPC/CHOLLiposomeslabeledwithDiA14913F60103F-DO-1DOPC/CHOLLiposomeslabeledwithDiO14743F60103F-DRDOPC/CHOLLiposomeslabeledwithDiR15083F60103F-DDDOPC/CHOLLiposomeslabeledwithDiD14913F60203F-DDOPC/CHOL/mPEG-DSPELiposomesLabeledwithDansylDOPE17123F60203F-FDOPC/CHOL/mPEG-DSPELiposomeslabeledwithFluoresceinDHPE16443F60203F-MBDOPC/CHOL/mPEG-DSPELiposomeslabeledwithMarinaBlue-DHPE19333F60203F-NBDDOPC/CHOL/mPEG-DSPELiposomesLabeledwithNBD-PE18483F60203F-OGDOPC/CHOL/mPEG-DSPELiposomeslabeledwithOregonGreen488DHPE18483F60203F-RDOPC/CHOL/mPEG2000-DSPELiposomeslabeledwithRhodamineDHPE16613F60203F-TCDOPC/CHOL/mPEG-DSPELiposomeslabeledwithTRITC-DHPE18313F60203F-TRDOPC/CHOL/mPEG-DSPELiposomeslabeledwithTexasRedDHPE18483F60203-PPlaceboControlDOPC/CHOL/PEG-DSPELiposomes13383F60203F-DDPEGylatedDOPC/CHOL/mPEG-PELiposomeslabeledwithDiD15593F60203F-DAPEGylatedDOPC/CHOLLiposomeslabeledwithDiA15593F60203F-DIPEGylatedDOPC/CHOLLiposomeslabeledwithDiI15083F60203F-DRPEGylatedDOPC/CHOLLiposomeslabeledwithDiR15763F60203F-DOPEGylatedDOPC/CHOLLiposomeslabeledwithDiO15423F60103F2-PPlaceboControlDOPC/CHOLLiposomes(200nm)forFluorescentliposomes14233newF60103F2-FFluorescentDOPC/CHOLLiposomeslabeledwithFluoresceinDHPE(200nm)16443newF60103F2-RFluorescentDOPC/CHOLLiposomeslabeledwithRhodamineDHPE(200nm)15933newF60103F2-TRFluorescentDOPC/CHOLLiposomeslabeledwithTexasRed488DHPE(200nm)17973newF70101C-NASEvaluationSamples:Clophosome(neutral)andClophosome-A(anionic)USA1700F70101C-N-2Clophosome,ClodronateLiposomes(Neutral)23383F70101C-N-10Clophosome,ClodronateLiposomes(Neutral)1011883F70101-N-2PlainControlLiposomesforClophosome(Neutral)21683F70101-N-10PlainControlLiposomesforClophosome(Neutral)105933F70101F-N-2FluorescentControlLiposomesforClophosome(neutral)22533F70101F-N-10FluorescentControlLiposomesforClophosome(neutral)108823F70101C-NC-2Combo:Clophosome-N(neutral)andControlLiposomes24063F70101C-NC-10Combo:Clophosome-N(neutral)andControlLiposomes1014263F70101C-NF-2Combo:Clophosome-N(neutrral),Fluorescent&PlainControlLiposomes26103F70101C-NF-10Combo:Clophosome-N(neutrral),Fluorescent&PlainControlLiposomes1022933F70101C-A-2Clophosome-A-ClodronateLiposomes(Anionic)25083F70101C-A-10Clophosome-A-ClodronateLiposomes(Anionic)1017833F70101-A-2PlainControlLiposomesforClophosome-A(Anionic)22533F70101-A-10PlainControlLiposomesforClophosome-A(Anionic)108823F70101F-A-2FluorescentControlLiposomesforClophosome-A(anionic)23383F70101F-A-10FluorescentControlLiposomesforClophosome-A(anionic)1011883F70101C-AC-2Combo:Clophosome-AandControlLiposomes25933F70101C-AC-10Combo:Clophosome-AandControlLiposomes1020723F70101C-AF-2Clophosome-A,Fluorescent&PlainControlLiposomes28823F70101C-AF-10Clophosome-A,Fluorescent&PlainControlLiposomes1034323F70101C-NA-2All-In-OneComboKit:Clophosome-A(anionic),Clophosome-N(neutral)-AndControlLiposomesforboth210183F70101C-NA-10All-In-OneComboKit:Clophosome-A(anionic),Clophosome-N(neutral)-AndControlLiposomesforboth1035683F70101C-NHHighPotencyClophosome-ClodronateLiposomes(Neutral,1.0mL,20mg/mL)18483newF1N5119PolycarbonateMembraneFilter(19mm,0.05um)12533newF1N8119PolycarbonateMembraneFilter(19mm,0.08um)12533newF1N10119PolycarbonateMembraneFilter(19mm,0.1um)11581newF1N20119PolycarbonateMembraneFilter(19mm,0.2um)11173newF1N40119PolycarbonateMembraneFilter(25mm,0.4um)11173newF1M10119PolycarbonateMembraneFilter(19mm,1.0um)11190newF1N5125PolycarbonateMembraneFilter(25mm,0.05um)12040newF1N8125PolycarbonateMembraneFilter(25mm,0.08um)11955newF1N10125PolycarbonateMembraneFilter(25mm,0.1um)11666newF1N20125PolycarbonateMembraneFilter(25mm,0.2um)11037newF1N40125PolycarbonateMembraneFilter(25mm,0.4um)11088newF1M10125PolycarbonateMembraneFilter(25mm,1.0um)11275[詳細(xì)]

  2018-09-29 10:02

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• abmart價(jià)格表

  訂貨電話4006551678艾比瑪特生物醫(yī)藥（上海）有限公司（以下簡(jiǎn)稱AbMART,公司網(wǎng)站：www.abmart.com.cn）是一家注冊(cè)于上海的生物技術(shù)外資企業(yè)。公司由留美學(xué)者,企業(yè)家和風(fēng)險(xiǎn)投資公司共同創(chuàng)辦，公司目標(biāo)是成為擁有Zxian極n單抗技術(shù)和Z完整抗體產(chǎn)品的yi流生物公司。Abmart是一家飛速發(fā)展的新星企業(yè)，從2006年創(chuàng)建以來，現(xiàn)在已經(jīng)有近100人的技術(shù)團(tuán)隊(duì)和每年能開發(fā)1000個(gè)單抗的技術(shù)平臺(tái)。Abmart是ZG目前Zda的抗體公司。AbMART的核心團(tuán)隊(duì)由7名博士（3名海歸+4名中科院博士），14名碩士，和17名本科組成，對(duì)抗體生產(chǎn)的每一步都進(jìn)行了科學(xué)合理的優(yōu)化來達(dá)到抗體生產(chǎn)的標(biāo)準(zhǔn)化、流程化、規(guī)模化，并針對(duì)國(guó)內(nèi)外市場(chǎng)提供抗體產(chǎn)品，診斷試劑盒開發(fā)，ZL性抗體的開發(fā)服務(wù)。在生物通網(wǎng)站（www.ebiotrade.com）舉辦的“年度生命科學(xué)排行榜”中，Abmart位列08生命科學(xué)應(yīng)屆畢業(yè)生Z想去的企業(yè)民營(yíng)企業(yè)板塊第五名；09生命科學(xué)**雇主（民營(yíng)企業(yè)）第六名。SantacruzABCAMCSTQIAGENSIGMAMERCKINVITROGENjacksonGEBDNEB批發(fā)中[詳細(xì)]

  2018-09-29 10:03

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• abnova價(jià)格表

  熱烈慶祝起福生物有限公司成為Zda的抗體和重組蛋白生產(chǎn)商Abnova的授權(quán)dai理商！Abnova公司是專注于高通量蛋白表達(dá)和抗體制作，并將的生物技術(shù)與臺(tái)灣IT工業(yè)管理經(jīng)驗(yàn)獨(dú)特融于一體的性生物公司。Abnova通過基因組學(xué)手段生產(chǎn)出的幾萬種重組蛋白和抗體，極大的擴(kuò)展了生物試劑應(yīng)用的視野和多樣性。同時(shí)，Abnova還在不斷的擴(kuò)展其在系統(tǒng)應(yīng)用中的產(chǎn)品線，包括成對(duì)抗體、ELISA試劑盒、原位雜交熒光探針、無表達(dá)蛋白定量以及可用于蛋白翻譯研究、診斷和制藥公司應(yīng)用的基礎(chǔ)型體外診斷設(shè)備等。作為Abnova的授權(quán)dai理商，艾美捷科技有限公司憑借豐富的專業(yè)經(jīng)驗(yàn)，將一如既往的為ZG區(qū)域客戶提供Abnova優(yōu)質(zhì)的產(chǎn)品和技術(shù)服務(wù)。憑借著duyi無二的市場(chǎng)支持以及銷售網(wǎng)絡(luò)，我們將一如既往的在ZG為Abnova用戶提供如下的金牌服務(wù)保障：１、更具品質(zhì)保障的Abnova抗體、抗體對(duì)以及重組蛋白等產(chǎn)品（Abnova作為多家知名抗體OEM商，能提供Z具性價(jià)比的產(chǎn)品）；２、更高價(jià)格優(yōu)勢(shì)和性價(jià)比的選擇，我們將一如既往的為客戶和dai理商提供Z具價(jià)格競(jìng)爭(zhēng)力的產(chǎn)品和全面的售后保障（作為全國(guó)總代理，我們能提供Zda的價(jià)格優(yōu)惠和更全面的技術(shù)支持）３、更快捷的到貨時(shí)間，我們將以更短的訂貨周期，更快捷的國(guó)際物流以及報(bào)關(guān)時(shí)間為您提供Z節(jié)省時(shí)間的供貨保證（艾美捷具有獨(dú)立的進(jìn)出口和報(bào)關(guān)權(quán)，因此提供更快捷的到貨保障）；[詳細(xì)]

  2018-09-29 10:03

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• listlabs價(jià)格表

  4006551678美國(guó)listlabs**代理細(xì)菌毒素listbiologicallaboratories公司是世界的科研毒素試劑供應(yīng)商，其毒素包括霍亂病毒，蛇毒，百日咳毒素等各類毒素,我公司常年低價(jià)供應(yīng),貨期快.有意者請(qǐng)聯(lián)系.分類貨號(hào)產(chǎn)品名稱規(guī)格Anthraxtoxins169AAnthraxLethalFactor（LF）,NativeSequencefromBacillusanthracis0.1mgAnthraxtoxins169BAnthraxLethalFactor（LF）,NativeSequencefromBacillusanthracis1mgAnthraxtoxins171AAnthraxProtectiveAntigen（PA）,RecombinantfromBacillusanthracis0.1mgAnthraxtoxins171BAnthraxProtectiveAntigen（PA）,RecombinantfromBacillusanthracis1mgAnthraxtoxins171CAnthraxProtectiveAntigen（PA）,RecombinantfromBacillusanthracis10mgAnthraxtoxins172AAnthraxLethalFactor（LF）,RecombinantfromBacillusanthracis0.1mgAnthraxtoxins172BAnthraxLethalFactor（LF）,RecombinantfromBacillusanthracis1mgAnthraxtoxins172CAnthraxLethalFactor（LF）,RecombinantfromBacillusanthracis10mgAnthraxtoxins173BAnthraxEdemaFactor（EF）,Recombinant,MutantS447NfromBacillusanthracis0.5mgAnthraxtoxins174AnthraxProtectiveAntigen,Activated（PA63）fromBacillusanthracis0.5mgAnthraxtoxins17nthraxPA63-FluoresceinIsothiocyanateConjugate（PAFITC）50ugAnthraxtoxins176AInactiveMutantLethalFactor（LF）,RecombinantfromBacillusanthracis0.1mgAnthraxtoxins176BInactiveMutantLethalFactor（LF）,RecombinantfromBacillusanthracis1mgAnthraxtoxins177AAnthraxProtectiveAntigenFragment（PA20）fromBacillusanthracis50ugAnthraxtoxins177BAnthraxProtectiveAntigenFragment（PA20）fromBacillusanthracis0.25mgAnthraxtoxins178AAnthraxEdemaFactor（EF）,RecombinantfromBacillusanthracis0.1mgAnthraxtoxins178BAnthraxEdemaFactor（EF）,RecombinantfromBacillusanthracis0.5mgAnthraxtoxins440ACELLWallfromBacillusanthracis5mgAnthraxtoxins440BCELLWallfromBacillusanthracis50mgAnthraxtoxins9171AQDAnthraxProtectiveAntigen（PA）,RecombinantfromBacillusanthracis0.1mgAnthraxtoxins9171BQDAnthraxProtectiveAntigen（PA）,RecombinantfromBacillusanthracis1mgAnthraxtoxins9172AQDAnthraxLethalFactor（LF）,RecombinantfromBacillusanthracis0.1mgAnthraxtoxins9172BQDAnthraxLethalFactor（LF）,RecombinantfromBacillusanthracis1mgAnthraxtoxins9172CQDAnthraxLethalFactor（LF）,RecombinantfromBacillusanthracis10mgBotulinumtoxins128ABotulinumNeurotoxinTypeAComplexfromClostridiumbotulinum10ugBotulinumtoxins128CBotulinumNeurotoxinTypeAComplexfromClostridiumbotulinum100ugBotulinumtoxins130ABotulinumNeurotoxinTypeAfromClostridiumbotulinum10ugBotulinumtoxins130BBotulinumNeurotoxinTypeAfromClostridiumbotulinum100ugBotulinumtoxins133ABotulinumNeurotoxinTypeAToxoid10ugBotulinumtoxins133BBotulinumNeurotoxinTypeAToxoid50ugBotulinumtoxins136ABotulinumNeurotoxinTypeB,Nicked,fromClostridiumbotulinum10ugBotulinumtoxins136BBotulinumNeurotoxinTypeB,Nicked,fromClostridiumbotulinum100ugBotulinumtoxins138ABotulinumNeurotoxinTypeBComplex,Nicked,fromClostridiumbotulinum10ugBotulinumtoxins138BBotulinumNeurotoxinTypeBComplex,Nicked,fromClostridiumbotulinum100ugBotulinumtoxins139BotulinumNeurotoxinTypeBToxoid10ugBotulinumtoxins140ABotulinumNeurotoxinTypeE,Nicked,ComplexfromClostridiumbotulinum10ugBotulinumtoxins140BBotulinumNeurotoxinTypeE,Nicked,ComplexfromClostridiumbotulinum100ugBotulinumtoxins141ABotulinumNeurotoxinTypeE,Nicked,fromClostridiumbotulinum10ugBotulinumtoxins141BBotulinumNeurotoxinTypeE,Nicked,fromClostridiumbotulinum100ugBotulinumtoxins143ExoenzymeC3fromClostridiumbotulinum50ugBotulinumtoxins610ABotulinumNeurotoxinTypeALightChain,Recombinant10ugBotulinumtoxins611ABotulinumNeurotoxinTypeALightChain,Recombinant,GSTFusion15ugBotulinumtoxins612ABotulinumNeurotoxinTypeAHeavyChain,Recombinant,BindingDomain50ugBotulinumtoxins613ABotulinumNeurotoxinTypeAGSTHeavyChain,Recombinant,BindingDomain50ugBotulinumtoxins620ABotulinumNeurotoxinTypeBLightChain,Recombinant10ugBotulinumtoxins622ABotulinumNeurotoxinTypeBHeavyChain,Recombinant,BindingDomain50ugBotulinumtoxins623ABotulinumNeurotoxinTypeBGSTHeavyChain,50ugBotulinumtoxins62BotulinumNeurotoxinTypeCLightChain,Recombinant10ugBotulinumtoxins630ABotulinumNeurotoxinTypeELightChain,Recombinant10ugBotulinumtoxins63BotulinumNeurotoxinTypeELightChain,Recombinant10ugBotulinumtoxins640BBotulinumNeurotoxinTypeFLightChain,Recombinant100ugBotulinumtoxins9128AQDBotulinumNeurotoxinTypeAComplexfromClostridiumbotulinum10ugBotulinumtoxins9128BQDBotulinumNeurotoxinTypeAComplexfromClostridiumbotulinum100ugBotulinumtoxins9130AQDBotulinumNeurotoxinTypeAfromClostridiumbotulinum10ugBotulinumtoxins9130BQDBotulinumNeurotoxinTypeAfromClostridiumbotulinum100ugCholeratoxin100BCholeraToxin（AZIDE-FREE）1mgCholeratoxin101ACholeraToxin0.5mgCholeratoxin101BCholeraToxin1mgCholeratoxin101CCholeraToxin2mgCholeratoxin102BCholeraToxinASubunit0.25mgCholeratoxin103BCholeraToxinBSubunit（Choleragenoid）1mgCholeratoxin103CCholeraToxinBSubunit（Choleragenoid）2mgCholeratoxin104CholeraToxinBSubunit（Choleragenoid）inLowSalt0.5mgCholeratoxin105CholeraToxinBSubunit-HorseradishPeroxidaseConjugate（BHRP）0.1mgCholeratoxin106CholeraToxinBSubunitFluoresceinIsothiocyanateConjugate（BFITC）0.2mgCholeratoxin107CholeraToxinBSubunitTetramethylRhodamineConjugate（BTRITC）0.2mgCholeratoxin112CholeraToxinBSubunitBiotinConjugate（BB）0.2mgDifficileToxins152AToxinAfromClostridiumdifficile2ugDifficileToxins152BToxinAfromClostridiumdifficile25ugDifficileToxins152CToxinAfromClostridiumdifficile100ugDifficileToxins153ToxinAToxoidfromClostridiumdifficile100ugDifficileToxins154AToxinBfromClostridiumdifficile20ugDifficileToxins154BToxinBfromClostridiumdifficile100ugDifficileToxins15ToxinBfromClostridiumdifficile2ugDifficileToxins155B<,/FONT>ToxinBfromClostridiumdifficile20ugDifficileToxins155CToxinBfromClostridiumdifficile200ugDiphtheriaToxin149DiphtheriaToxinCRMMutant1mgDiphtheriaToxin150DiphtheriaToxin（unnicked）1mgDiphtheriaToxin151DiphtheriaToxoid0.5mgFretpeptidesandnativesubstrates500ASNAP-25RecombProteinSubstrateforC.botulinumTypesAandENeurotoxin100ugFretpeptidesandnativesubstrates510AGSTSynaptobrevin-2RecombProteinSubstrateforC.botulinumTypesB,D,FandG100ugFretpeptidesandnativesubstrates520SNAPtidePeptideSubstrate（o-Abz/Dnp）forClostridiumbotulinumTypeANeurotoxin200nmolFretpeptidesandnativesubstrates521SNAPtidePeptideSubstrate（FITC/DABCYL）forClostridiumbotulinum200nmolFretpeptidesandnativesubstrates525ControlPeptideforSNAPtide520200nmolFretpeptidesandnativesubstrates528UnquenchedCalibrationPeptideforSNAPtide52150nmolFretpeptidesandnativesubstrates529UnquenchedCalibrationPeptideforSNAPtide52050nmolFretpeptidesandnativesubstrates530MAPKKidePeptideSubstrate（o-Abz/Dnp）forAnthraxLethalFactor200nmolFretpeptidesan,dnativesubstrates531MAPKKidePeptideSubstrate（DABCYL/FITC）forAnthraxLethalFactor200nmolFretpeptidesandnativesubstrates539MAPKKideUnquenchedCalibrationPeptidefor530forAnthraxLethalFactor50nmolFretpeptidesandnativesubstrates540VAMPtidePeptideSubstrate（o-Abz/Dnp）200nmolFretpeptidesandnativesubstrates541VAMPtidePeptideSubstrate（FITC/DABCYL）200nmolFretpeptidesandnativesubstrates549CALIBRATIONFLUOROPHOREforVAMPtide540100nmolFretpeptidesandnativesubstrates550SNAPEtidePeptideSubstrate（o-Abz/Dnp）forC.botulinumTypeENeurotoxin150nmolFretpeptidesandnativesubstrates560SYNTAXtide（o-Abz/Dnp）PeptideSubstrateforC.botulinumTypeCNeurotoxin200nmolLipopolysaccharides（LPS）201LPSfromEscherichiacoliO111:B45mgLipopolysaccharides（LPS）203LPSfromEscherichiacoliO55:B55mgLipopolysaccharides（LPS）206LPSfromEscherichiacoli0157:H710mgLipopolysaccharides（LPS）225LPSfromSalmonellatyphimurium5mgLipopolysaccharides（LPS）301LPSfromEscherichiacoliJ5（Rc）5mgLipopolysaccharides（LPS）302LPSfromEscherichiacoliK12,D31m4（Re）5mgLipopolysaccharides（LPS）304LPSfromSalmonellaminnesotaR595（Re）5mgLipopolysaccharides（LPS）314LPSfromEscherichiacoliK12strainLCD251mgLipopolysaccharides（LPS）401LIPIDA（primarilymonophosphoryl）fromSalmonellaminnesotaR5951mgLipopolysaccharides（LPS）402LIPIDA（primarilydiphosphoryl）fromEscherichiacoliK12,D31m41mgLipopolysaccharides（LPS）421ULTRAPURELPSfromEscherichiacoliO111:B41mgLipopolysaccharides（LPS）423ULTRAPURELPSfromEscherichiacoli055:B51mgLipopolysaccharides（LPS）434ULTRAPURELPSfromSalmonellaminnesotaR595（Re）1mgOthertoxins120AlphaToxinfromStaphylococcusaureus0.25mgOthertoxins122EnterotoxinTypeBfromStaphylococcusaureus0.5mgOthertoxins156PasteurellaMultocidaToxin50ugOthertoxins160ExotoxinAfromPseudomonasaeruginosa1mgOthertoxins165BHEATLABILETOXINfromEscherichiacoli0.5mgOthertoxins188AdenylateCyclaseToxinfromB.pertussis50ugOthertoxins199TetanolysinfromC.tetani100ugPertussisToxins170FilamentousHemagglutinin（FHA）50ugPertussisToxins179APertussisToxinIsletActivatingProtein（inGlycerol）50ugPertussisToxins179BPertussisToxinIsletActivatingProtein（inGlycerol）200ugPertussisToxins180PertussisToxinIsletActivatingProtein,LyophilizedinBuffer50ugPertussisToxins181PertussisToxinIsletActivatingProtein,Lyophilized（Salt-Free）50ugPertussisToxins182PertussisToxinAProtomer10ugPertussisToxins183PertussisToxinBOligomer40ugShigalikeToxins161ShigaToxin1fromE.colirecombinant10ugShigalikeToxins162ShigaToxin2fromE.colirecombinant10ugShigalikeToxins164ShigaToxin2（verotoxin2）fromE.coliO15710ugTetanusToxins190ATetanusToxin25ugTetanusToxins190BTetanusToxin100ugTetanusToxins191ATetanusToxoid25ugTetanusToxins191BTetanusToxoid100ugTetanusToxins193TetanusToxinCFragment10ugTetanusToxins196ATetanusToxinCFragmentFluoresceinIsothiocyanateConjugate（CFITC）10ugTetanusToxins650ATetanusToxinLightChain,Recombinant10ugAntiseraandAntibodies703Anti-CholeraToxinBSubunit（Goat）0.1mlAntiseraandAntibodies730AAntti-BotulinumNeurotoxinTypeA（ChickenlgY）0.1mgAntiseraandAntibodies736AAnti-BotulinumTypeB（ChickenlgY）0.1mgAntiseraandAntibodies752Anti-ToxinAfromClostridiumdifficile（Goat）0.5mlAntiseraandAntibodies753AAnti-ClostridiumdifficileToxinA（ChickenlgY）0.1mgAntiseraandAntibodies760Anti-ExotoxinA（Goat）1mlAntiseraandAntibodies763Anti-ShigaToxin1fromE.Coli（MouseIgG1-κ）monoclonal100ugAntiseraandAntibodies764Anti-ShigaToxin2fromE.Coli（MouseIgG1-κ）monoclonal100ugAntiseraandAntibodies771BAnti-ProtectiveAntigenfromBacilliusanthracis（Goat）1mgAntiseraandAntibodies772BAnti-LethalFactorfromBacilliusanthracis（Goat）1mgAntiseraandAntibodies773BAnti-EdemaFactorfromBacilliusanthracis（Goat）1mg[詳細(xì)]

  2018-09-29 10:03

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• Fitzgerald2015Zxin價(jià)格表

  多產(chǎn)品信息請(qǐng)來電咨詢我們，上海起發(fā)實(shí)驗(yàn)試劑有限公司電話：4006551678企業(yè)QQ：4006551678EMAIL：fige007@163.com正規(guī)代理品牌1：PolysciencesInc，ABBiolabs，abbexa，AcrisAntibodies，arcticzymes，AROTEC，Athens，AvesLabs,Inc.BangsLaboratories，BBI，bellbrooklabs，GREER，Biorelevant，Biosearch，chiralix，ColumbiaBiosciences，Crystalchem，DianovaEnzymeResearch，F(xiàn)DNEURO，F(xiàn)ITZGRALD，F(xiàn)ormuMax，GelcompanyGeneBridgesGmbH，Glycotope，HyglosGmbH，iduron，Immudex，immunoGlob，InnovativeResearch，iris-biotech，kalenbiomed，Ludger，Microspheres-nanosphere，Mybiosource，nanocomposix，nanotools，NeuroProbe，nibsc，OLIGOENGINE，pentapharm，ProQinase，prospec，QA-Bio,Inc，QuickZymeBiosciences，researchdiets，SantaCruz,springbio，synapticsystem，TriLinkBioTechnologies,Inc.，ViagenBiotech，ImmunologicCorporation，ZyagenLaboratories，ZYGEMCorpLtd，Alomone，medicago，BIOCHAIN[詳細(xì)]

  2018-10-06 10:00

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  • 

• ATOS比例閥|atos比例閥接線解決方案

  ATOS比例閥|atos比例閥接線解決方案[詳細(xì)]

  2018-09-27 10:00

  產(chǎn)品樣冊(cè)

  |

  • 
  • 
  • 
  •